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Abstract
This study aims to assess the interactions between antibiotic resistance and the ability of heterotrophs ef-
fected by highly polluted environments to remediate antibiotics from soil via biodegradation. These findings
would reveal whether a self-cleaning process is occurring in the waters of Western NY. Water and sediment
heterotrophs were obtained from wastewater contaminated environments to understand the factors influenc-
ing metabolism. A total of 113 isolates from Charlotte, Durand, and Payne Beaches, the Genesee River,
and Hemlock Lake were cultured and detected for antibiotic resistance to 24 different antibiotics. Of these,
seven robust bacteria from sediments were considered for their ability to use a single antibiotic as their sole
carbon source — available carbon limited substrate utilization. Microbes were able to remediate antibi-
otic substrates from soil between 18.1-42.1% at one-times the concentration, whereas two and three times
the original concentration was impotently degraded by 13.4-24.0% and 5.7-18.2%, separately. Heterotrophs
also demonstrated unique substrate binding affinity for alternative substrates, which were discovered to be
degraded between 1.05% to 72.96%. We found the best alternative substrates with enzyme activity to be
tetracycline (70.26-72.96%), chloramphenicol (49.28-66.78%), and trimethoprim (54.51-57.22%). An as-
sessment of antimicrobial susceptibility revealed that the highest resistance was observed to aminoglycoside
antibiotics, followed by cephalosporins, beta-lactams, and fluoroquinolones. A robust isolate from Durand
Beach was resistant to 19 out of the 24 antibiotics under evaluation. We posit that heterotrophs of highly
polluted environments are restricted by carbon-availability, have unique binding affinity for alternative sub-
strates, and are multidrug-resistant.
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Chapter 1
Introduction and literature review
1.1 Overview
The use of antibiotics has revolutionized medicine while inadvertently making it increasingly complicated
to treat disease [1] due to the development of extensively drug-resistant (XDR), multidrug-resistant (MDR),
and pandrug-resistant (PDR) pathogens [2], [3]. Since their debut, world-wide yearly antibiotic consumption
in 2002 [4] was estimated between 100 to 200 thousand tonnes, over 1 million tonnes in 2010 [5], and now
calculated to be between 8.9 to 17.8 million tonnes per year.
The rise of antibiotic resistance has been deemed a public health threat across the globe [1], [6], [7]. Con-
tributing factors to the occurrence of environmental resistance have been attributed to the overuse and misuse
of antibiotics in clinical and veterinary settings [1], [7]. The sharing of resistance genes among bacteria in
the environment has facilitated human-pathogen acquired resistance [8], through selective pressures leading
to natural selection.
Industrial facilities and animal farms act as hot spots for antibiotic resistance genes (ARGs), promoting
the evolution of antibiotic resistant (AR) bacteria through selective pressures. Waste from these facilities,
containing AR bacteria, ARGs, and antibiotics, is discharged into the environment where it leaches into
groundwater and eventually flows into our rivers and oceans [1], [9]–[14].
Drinking water quality standards have been under speculation as chemicals, such as pharmaceuticals,
are not regulated [15], and consequently, pharmaceutical levels have been detected in drinking water [16].
Extended exposure to these chemicals through drinking water poses questions about health risks. Thus,
pharmaceuticals have been deemed an emerging chemical contaminant, and extensive research has been
put towards removal techniques [9], [15]. Remediation of antibiotics from natural waters, sediments, and
wastewater can be achieved by use of nanomaterials [17], abiotic and biotic biodegradation [18], and the use
2
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of bioengineered strains [19].
Bioremediation of environmental contaminants involves the use of antibiotic substrates as a carbon source.
This study aims to heighten the understanding of the factors that impact the biodegradation of antibiotics in
polluted environments. The correlation between antibiotic contaminant removal potential via biodegradation
and the occurrence of antibiotic resistance in heterotrophs were also under investigation.
1.2 Release of antibiotics into the environment
Heterotrophic microorganisms are ubiquitous in the environment and use organic matter for growth [20].
The release of antibiotics into the environment has been linked to antibiotic resistance of human pathogens,
provoking challenges for practitioners when treating disease [21]. Sewage overflow, agricultural runoff,
incomplete removal by , and the overuse and misuse of antibiotics are a few of the mechanisms by which
antibiotics get in contact with environmental microorganisms.
The Journal of Clinical Infectious Diseases reported that in 2011 there were 60.3 million penicillins,
59.1 million macrolides, 35.6 million cephalosporins, 27.6 million fluoroquinolones, and 21.6 million beta-
lactam outpatient prescriptions in the United States [22], inducing a high selective pressure for environmental
microbes.
In addition to the use of antibiotics in human medicine, antibiotics are popularly used in farming [23][24]
and aquaculture as preventative measures for disease, likely to meet the public demand for meat consump-
tion [1], [7]. Incomplete metabolism of antibiotics in humans and livestock results in excretions containing
antibiotic concentrations [1], [11]. Sewage and wastewater contain human excretions which can include
trace levels of pharmaceutical antibiotics. Researchers report on the excretion rates of several active sub-
stances: 80% ampicillin, 80% streptomycin, 85% cefepime, and 70% levofloxacin (structurally similar to
lomefloxacin) [25].
Pharmaceuticals secreted in urine can outflow into water bodies, exposing bacteria to harmful toxins,
thereby inducing evolutionary adaptations for survival. Sewage and animal manure runoff into water bodies,
eventually making way to inline and drinking water facilities that are not equipped to eliminate antibiotics
[13], [14], [26]. Similarly, agricultural soils use biosolids as additives [27]. During precipitation, agricultural
soils runoff into water systems. A sewage sludge mesocosm experiment in the United States detected the dry
weight concentrations of lomefloxacin at 2.7 µg/kg [27]. The lack of methods by which inline are equipped
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to eliminate trace levels of antibiotics from influent pose concerns for the public through the emergence of
antibiotic-resistant pathogens.
1.3 Antibiotics under investigation
Within this study, antibiotics used to treat various clinical infections either singly or in combination [28]–
[32] (ampicillin, cefepime, lomefloxacin, or streptomycin) were used to select for sediment bacteria capable
of substrate degradation. These drugs are of relative significance as they are currently being used in hospi-
tal settings for the treatment of disease, and a better understanding of the interactions between antibiotics
(synthetic and natural) and microbes in the environment is paramount.
Combination drug therapy is used for the treatment of MDR and XDR. When treating resistant hospital-
acquired pneumonia, it is required to treat patients with broad-spectrum antibiotics (i.e., cefepime, lev-
ofloxacin) alone or in combination [32], [33]. When MDR is a concern, an aminoglycoside or colistin is
added to the mix [32].
In practice, multidrug-resistant urinary infections, neurosurgical procedure infections, and tuberculosis
have been treated with lomefloxacin, broad-spectrum antimicrobial therapy (vancomycin, a third or fourth
generation cephalosporin, and metronidazole), and streptomycin, respectively [28]–[30]. As more drugs are
introduced for the treatment of infections, the ability of microbes to combat these drugs or a combination of
these drugs, is imminent.
1.4 Occurrence of antibiotics in the environment
Worldwide reports have detected antibiotics at high concentrations in aquatic environmental ecosystems.
Ampicillin has been detected in water, hospital effluent, and wastewater effluent at concentrations of 0.016
µg/ml [34], 0.028-0.0827 µg/ml [25], and 70.6 µg/ml [35], respectively. The other antibiotics under inves-
tigation within this study have been detected at levels in the ng/L [36]–[39], but have not been studied as
extensively.
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1.5 Occurrence of antibiotic resistance in environmental ecosystems
The resistance of antibiotics in the environment has been studied to a great extent across the world, with
percentages of resistant cultured microbes ranging drastically by geographic location, signifying a need for
site-specific analyses [15]. In aquatic environments, the resistance of water Escherichia coli isolates during
winter from a river in India demonstrated antibiotic resistance of 39% ampicillin and 10% cefepime [40]. In
the same study, the resistance of sediment E. coli isolates during winter exhibited 30% resistance to ampicillin
and 15% resistance to cefepime [40].
The percent resistance of E. coli isolates from a creek in British Columbia were reported as 16% to
ampicillin, 8% to streptomycin, 0.5% to ciprofloxacin, and 59% to tetracycline [41]. Significantly, this study
found higher antibiotic resistance in biofilms and sediment in contrast to water isolates [41].
1.6 Acquisition of antibiotic resistance genes (ARGs) in environmental microorganisms
Plasmids of microorganisms can contain a wide range of antibiotic resistance genes (ARGs). Many gene
cassettes, genetic material encoding for antibiotic resistance can comprise a single integron [42], which then
inserts into a transposon [43]. Transposons containing various sets of ARGs can insert into a plasmid to
confer antibiotic resistance when it is evolutionarily advantageous for the cell. Additionally, transposable
elements can move freely throughout the host genome, inserting sequences into host deoxyribonucleic acid
(DNA) or plasmids. Plasmids can be shared between bacterial species through a process called conjugation
[44], allowing antibiotic resistance to be widespread within bacterial populations.
Plasmids containing ARGs can be selected for by the exposure of microbes to any selective antibiotic that
the plasmid confers resistance to [43]. Consequently, other ARGs existing on the same plasmid would be
co-selected through the initial exposure to a single selective antibiotic [43].
In a study by [45], the selection of multiresistance by microbes in freshwater microcosms through en-
richment of isolates to toxicant concentrations above levels typically exhibited in the environment was under
investigation. The exposure of microorganisms to toxicants was proven to increase the frequency of multiple
antibiotic resistance to unrelated antibiotics [45].
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1.7 Threat to living organisms
Prior studies examined the connection between environmental antibiotic resistance and human-pathogen ac-
quired resistance. A study in Egypt on Gram-negative bacteria in cancer patients found the resistance of E.
coli isolates at 100% for ampicillin, 91% for amoxicillin/clavulanic acid, 94% for cefepime, 79% for lev-
ofloxacin, and 94% for trimethoprim/sulfamethoxazole, among several other clinically significant antibiotics.
Findings of this study are of particular significance as cefepime, penicillins, and third and fourth generation
cephalosporins exhibited high microbial resistance in patients [46].
In addition to the effects on public health, anthropogenic environmental toxicants threaten sensitive
aquatic ecosystems. Recent studies found pharmaceuticals and personal care products (PPCPs) at concentra-
tions in rivers that are of high or medium risk to living organisms [47]. In particular, the out-competition of
naturally occurring microorganisms poses threats for fish and benthic invertebrates that require commensal
bacteria for survival. Additionally, higher level organisms undergo bioaccumulation and biomagnification of
aquatic pollutants [48], [49]. Research findings demonstrated the bioaccumulation of sulfonamides, trimetho-
prim, and fluoroquinolones in fish muscle tissue, and macrolide antibiotics in fish liver tissue [50]. The food
chain may biomagnify environmental pollutants through trophic levels, and exposure of humans to these tox-
icants. The pollution of our freshwater bodies impacts the alteration in the balance of the ecosystem and must
be monitored and controlled to preserve the environment for future generations to appreciate.
1.8 Existing solutions
In recent years, scientists have pushed the discovery of cutting-edge antibiotics in the fight against antibiotic
resistance. In particular, a new class of antibiotics was discovered using revolutionary iChip technology,
which cultures microbes outside of the lab [21] — the new antibiotic, teixobactin, aids in the fight against
superbugs [51].
Millions of dollars in funding goes toward the fight against antibiotic resistance in the United States.
Implementations have been taken to reduce the distribution of antibiotics at the source [52]–[54]. The Centers
for Disease Control and Prevention (CDC) implemented a risk-assessment to monitor antibiotic usage (AU),
the standardized antimicrobial administration ratio (SAAR), to statistically compare the ratio of antimicrobial
therapy measured in days [53].
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Despite a wide range of solutions to fight antibiotic resistance, limitations persist, and recommendations
propose a better understanding of the toxicology and fate of chemicals in the environment [26]. The methods
by which antibiotics disseminate into the environment have been studied extensively, though knowledge
gaps remain as data varies geographically [15]. Advanced wastewater removal technologies exist, like, the
emerging field of nano-materials which is promising for nano-remediation of chemicals of concern from
effluent [26]. Alternative methods, like membrane bioreactors, appear to be effective but have operational
drawbacks in terms of cost [26].
Prevention and restrictions on AU in practice assist in reducing the number of antibiotics released into
the environment where contact with environmental microorganisms occurs. Appropriate antibiotic usage is a
leap towards reducing the development of antibiotic resistance. Studies must be keen on tracking antibiotic
resistance in the human microbiome and other organismal reservoirs. With the exposure of environmental
microorganisms to high concentrations of synthetic and natural antibiotics, it is natural for organisms to
compete for survival, giving rise to the deadliest of bugs [52], [53].
1.9 Objectives
Despite the vast array of scientific data available on microbial resistance, knowledge gaps remain concerning
the roles of antibiotic substrate utilization in aquatic ecosystems. This study aims to develop a better under-
standing of the role of antibiotic resistance and biodegradation of antibiotics as substrates in the environment.
The objective of this study is to evaluate the resistance of microbes to 24 different antibiotics in wastewater
contaminated surface water and sediments. The second objective is to heighten the understanding of the
impacts of carbon-limitation and substrate availability on microbial isolates cultured from sediment. This
study is unique in the way that extremely high antibiotic concentrations (500 µg/ml-25000 µg/ml) were used
throughout our experiments.
1.10 Research hypothesis
The fate of antibiotic pollutants has sparked interest more recently as public health continues to deteriorate
as a result of human-acquired pathogen resistance; facilitated by lack of removal efficacy by WWTPs and
persistence of these compounds in the environment. Prior studies have suggested that some pharmaceuti-
cal compounds may be highly degradable [55], indicating a present knowledge gap in understanding the
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metabolism of these compounds in the environment.
This study aims to gain a better understanding of antibiotic microbial metabolism from contaminated and
uncontaminated sites, while simultaneously addressing antibiotic resistance in robust isolates. By gathering
microbiological evidence, this study attempts to confirm in situ microbial metabolism by establishing an
understanding of carbon-limitation and substrate-specificity in isolates from sampling sites in Western New
York (WNY).
Even though the environment contains high concentrations of various antibiotics, we propose that micro-
bial metabolism is limited by antibiotic carbon-availability and maximized by alternate substrates. Results in-
dicate that degradation capacity is weakly substrate-specific and restricted by increases in carbon-availability.
Chapter 2
Materials and methods
2.1 Sampling sites
During summer and fall of 2017, aquatic grab samples within the littoral zone of both surface water and
disturbed surface sediments were obtained from Charlotte, Durand, and Payne Beaches, the Genesee River,
and Hemlock Lake. Grab samples were obtained using a 500 ml graduated water dipper. Sediment and water
samples were taken within 18 meters of where the water meets the shore. Within this study, sampling sites
were impacted by flooding and wastewater discharge. Summer samples were obtained on May 23, 2017, and
fall samples were obtained on October 29, 2017.
Figure B.4 shows the geographic locations of sampling points. Samples were taken from unusual loca-
tions during the summer, as historical flooding was present. Observation of Payne Beach revealed significant
flooding. Additionally, Durand Eastman had no beach, Charlotte only had 40% of the beach present, the
Hemlock water level was almost up to the road, and there was no difference in the sample location for the
Genesee River. In the fall, 20-30% of Charlotte beach and 80% of Durand had receded, Payne Beach was
down to the effluent pipe, and Hemlock beach returned to normal levels.
The resistance of heterotrophs in WNY was quantified through the evaluation and comparison of several
point sources. The control within this study was Hemlock Lake as it is used as drinking water for the City
of Rochester [56]. Wastewater effluent is discharged into three of the other sources, Durand, Charlotte, and
Payne Beach. Of which, two of these point sources, Durand and Charlotte, are used by the general public as
recreational swimming areas. Samples were also obtained and analyzed from the Genesee River, which is
exposed to agricultural runoff through manure used on cornfields.
For Payne Beach, wastewater effluents release from the Northwest Quadrant wastewater treatment plant
(WWTP), and there is the potential for runoff from migratory birds as this area is the western region of
9
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Braddock Bay Wildlife Refuge [57], [58]. The Genesee River receives agricultural runoff from nearby fields
that apply manure and pesticides to crops which can runoff into the river.
2.2 Environmental pollution
Coordinates of sampling locations were uploaded into ArcGIS Pro as X and Y data. A multipart buffer layer
was created including one, five, and ten miles to determine WWTPs near sampling sites that may impact
water quality. Using the United States (U.S.) Environmental Protection Agency (EPA) Enforcement and
Compliance History Online (ECHO) website, discharge facilities classified as "major facilities" which were
located within the hydrologic unit code (HUC) 8 watershed boundaries of each sampling site were added as
points to the map [59]. The HUC 8 watershed boundaries were retrieved from the United States Department
of Agriculture (USDA) Geospatial Data Gateway [60].
2.3 Bacterial populations
Laboratory methods followed the flow chart as outlined in Figure B.1. Samples obtained at indicated sam-
pling locations (Figure B.4) were enumerated in triplicates. Viable cell count means were calculated using
International Business Machines Statistical Package for the Social Sciences (IBM SPSS) computer software
for Charlotte, Durand, Genesee, Hemlock, and Payne in summer and fall for both water (Figure 3.4) and sed-
iment (Figure 3.5) samples in order to obtain an understanding of the number of culturable microorganisms
present in a particular sample [61]. The enumeration of heterotrophs from freshwater is used as an indicator
of water quality changes after treatment [20].
Triplicate serial dilutes of water, and sediment grab samples for each sampling site provided statistical
accuracy of data through enumeration of colonies after 10 days of incubation at room temperature for di-
lutions of 10−5. colony-forming units per milliliter (CFU/ml) for water and sediment were determined by
multiplication of the dilution factor.
Water and sediment samples were titered in 1 ml from 10−1 to 10−5 in 0.9% saline solution. Triplicate
serial dilutions of samples were pipetted onto R2A media (100 µL) from 10−5 to 10−7 using the spread plate
method. Samples were incubated at 22 ± 2◦C and enumerated at 2, 5, 7, and 10-days. Figure B.5 details the
serial dilution technique used for water and sediment sample microbial viable cell counts.
0.9% saline solution was prepared and then sterilized with a 0.22 µm filter sterilizer then transferred in 9
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ml increments to 15 ml sterile conical tubes. Reasoner’s 2A (R2A) media is used to select for and enumerate
heterotrophic microbes in potable water. R2A media was prepared using the standard protocol.
2.4 Culture enrichment for the isolation of acclimated bacteria
Through the creation of enrichment cultures (Figure B.6), heterotrophic microorganisms capable of survival
with antibiotics from sediment were selected throughout 21-days and growth was measured using spec-
troscopy. Similar methods, such as the automated checkerboard array, use printer technology to measure
the growth of cultures with various levels of antibiotics in synergy [62].
Enrichment cultures consisted of antibiotic-amended culture broth. Following 7 days of incubation, the
qualitative turbidity of enrichment culture was observed and recorded (Tables A.12 and A.13). Turbidity was
measured by observable cloudiness of the sample as a technique for the determination of microbial presence
within the sample. If turbidity was not detected after 7 days of incubation, then the flasks were kept in the
incubator for 7 additional days until cloudiness was observed.
Bushnell Haas broth was prepared using the following standard protocol. Into 1 liter of DI H2O, 3.7
grams of Bushnell Haas broth was suspended and mixed. The pH was adjusted to 7-7.2 when necessary.
Sterilization of the broth was either achieved through the use of 0.22-micron filter units or by autoclaving at
121°C for 20 minutes. The sterile broth was stored at room temperature in sealed bottles when not in use.
The enrichment technique includes samples amended with selective antibiotics for a duration of 21-days.
Several different antibiotic stock solutions were prepared and added to cultures containing sediment to isolate
potential antibiotic degraders. The following antibiotics were used: ampicillin, cefepime, lomefloxacin, and
streptomycin. Preparation of antibiotic stocks followed the mass and volumes included in Table A.5. Using
the equation for mass concentration (1), where the density (ρ) of a substance is equal to the concentration by
dividing the mass of solute (m) by the volume of solvent (V), antibiotic stock concentrations were calculated.
Sterilization of stock solutions was performed using 0.22 µm filter sterilizers then transferring the 20 ml stock
solution to 50 ml sterile conical centrifuge tubes for storage in the refrigerator when not in use.
ρ =
m
V
(1)
Antibiotic stocks were utilized to make three sets of enrichment cultures; in total there were 20 flasks.
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Enrichment cultures for summer samples were prepared using sediment source samples. Through the ad-
dition of 5 ml of sample sediment with 1 ml of antibiotic stock (ampicillin (7500 µg/ml), cefepime (7500
µg/ml), lomefloxacin (25000 µg/ml), or streptomycin (10000 µg/ml)) and 44 ml Bushnell Haas in a 125 ml
Erlenmeyer flask, respectively, enrichment cultures were created. Flasks were incubated for seven days of
shaking incubation (120 revolutions per minute (rpm) at room temperature).
Visual detection of turbidity was performed for enrichment one after seven days of incubation. Before
subculturing enrichments 2 and 3, at 14 and 21-days, turbidity was assessed. The subculturing process
is illustrated in Figure B.6. For the following enrichments, fresh media was used to subculture the cells.
Enrichment stocks were incubated and re-incubated shaking at 120 rpm and 22 ± 2◦C. For enrichment 2, at
14 days, the enrichment culture was titered in 0.9% saline from 10−1 to 10−5 and plated by 100 µl increments
onto R2A media from 10−4 to 10−7 using the spread plate method. The dilution process for enrichments is
demonstrated in Figure B.7. Plates were incubated at room temperature and enumerated for 2, 5, 7, and
10-days. Enrichment cultures at 21-days were titered and plated onto R2A media as was conducted with
enrichment 2. Fall sample processing followed the same methods as summer enrichment culture.
Further analysis included the collection of all colonies with growth on plates of 10−7at 10-days from
enrichment three. Colonies were isolated using a sterile inoculating loop and spread onto R2A media using
the T-streak method. Following 48 hours of incubation at room temperature, isolated colonies were inoculated
into the sterile nutrient broth to ensure pure cultures. Following 48 hours of shaking incubation of 120 rpm
at room temperature in flasks, isolates were re-streaked onto R2A media. Colony morphology was observed
after 48 hours of incubation at room temperature and characterized by form, elevation, margin, and color.
2.5 Growth of acclimated bacteria on substrates for the determination of robustness
The ability of selected heterotrophs to thrive in an environment with high concentrations of enriched an-
tibiotic was quantified through absorbance measured at 600 nanometers via ultraviolet−visible spectroscopy
(UV/Vis). Through growth analysis experimentation, we investigated heterotrophic cellular growth in culture
media. Isolated enrichment 3 colonies were observed for the ability to not only co-exist with high antibi-
otic concentrations but also to multiply and divide in the presence of a single antibiotic of which they were
initially enriched.
The growth of enrichment isolates on a particular antibiotic was quantified by UV/Vis spectroscopy.
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Microorganisms were isolated from summer and fall enrichment 3 samples (Figures 4.1 and 4.2).
Isolates from the enrichment phase were further inoculated into 125 ml Erlenmeyer flasks containing 10
ml nutrient broth for 48 hours, shaking (120 rpm at room temperature). Isolates were then centrifuged in
sterile 15 ml conical tubes for harvesting. Following centrifugation, the supernatant was removed, and a
pipette was used to resuspend the pellet of cells into 2 ml of Bushnell Haas media.
In a 125 ml Erlenmeyer flask, 9.6 ml of Bushnell Haas media was added with 0.2 ml resuspended cells, re-
trieved from enrichment centrifugation and suspension, and 0.2 ml of the antibiotic (ampicillin (7500 µg/ml),
cefepime (7500 µg/ml), lomefloxacin (25000 µg/ml), or streptomycin (10000 µg/ml)) of which the sample
was enriched for, respectively. The flasks were incubated at room temperature, shaking at 120 rpm. The
absorbance of these cultures was measured at 0, 2, 4, 6, 8, and 10-days by retrieving 0.3 ml of respective
samples and re-incubating. A quartz cuvette with deionized water was used as a control for the UV/Vis spec-
trophotometer. With a pipette, 0.3 ml of the respective sample was pipetted into a quartz cuvette along with
1.2 ml of deionized water to measure the absorbance at 600 nanometers.
Utilizing the methods by Gallagher (2016) [63], generation of cells (G) (2) and growth rate (k) (3) were
determined using the following calculations where N1 represents the lower absorbance, and N2 equals the
higher absorbance measured at 600 nanometers.
G =
duration× log10 (2)
log10 (N2)− log10 (N1)
(2)
k =
0.693
G
(3)
2.6 Growth of robust isolates on alternative substrates
Colonies that exhibited a short doubling time and large growth rate from the initial growth analysis with
antibiotics used for selection were chosen for further analysis of enrichment on antibiotics from different
classes. Table A.14 indicates high capacity isolates that were chosen along with the different enriched antibi-
otics. Isolation of colonies followed the same procedure as previously mentioned.
In a 125 ml Erlenmeyer flask, 9.6 ml of Bushnell Haas media was added with 0.2 ml resuspended cells
(from the 48 hour nutrient broth culture) and 0.2 ml of the antibiotic (6250 µg/ml amoxicillin, 1250 µg/ml
chloramphenicol, 12500 µg/ml erythromycin, 25000 µg/ml levofloxacin, 500 µg/ml tetracycline, 2500 µg/ml
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trimethoprim) in accordance with Table A.5, respectively. The flasks were incubated at room temperature,
shaking at 120 rpm. The absorbance of each sample at 600 nm was measured at 0, 2, 4, 6, 8, and 10-days. A
quartz cuvette with deionized water was used as a zero for the UV/Vis spectrophotometer. With a pipette, 0.3
ml of the sample was pipetted into a quartz cuvette to measure the absorbance at 600 nm along with 1.2 ml
of Bushnell Haas media. The dilution factor was five.
2.7 Degradation of antibiotics from soil by robust isolates
Robust heterotrophs initially selected for in antibiotic-amended culture were chosen for biodegradation mea-
surements on varying concentrations of the selected pharmaceutical (Tables 4.3 and 4.4). Isolates were in-
oculated in 10 ml of nutrient medium in flasks in the shaking incubator at 120 rpm and 22 ± 2◦ Celsius.
Following 72 hours of incubation, 3 ml of cells were aseptically removed from the test tubes and placed into
two sterile 1.5 ml microfuge tubes. Cells were centrifuged at 13,000 rpm for 5 minutes. The supernatant was
poured off, and the cells were resuspended in the first microfuge tube with 1.0 ml of Bushnell Haas medium.
The first microfuge tube was used to resuspend the cells in the second microfuge tube.
The following reagents were prepared for biometer experiments using standard protocol: 1% phenolph-
thalein, 0.05 N HCl, 0.2 N KOH, and 0.334 g/ml saturated barium chloride. Preparation of biometer flasks
included the addition of 48 ml of Bushnell Haas medium to each flask, 1.0 ml of cells, and then 1.0 ml of
antibiotic to the flask. Ascarite was added to the tower, and 10 ml of fresh KOH was added to the sidearm.
The flask was incubated at room temperature. Biodegradation analysis of selected antibiotics consisted of the
determination of isolate degradation rates of the antibiotic at one, two, and three-fold concentrations (Tables
4.3 and 4.4).
Samples of KOH for measuring carbon dioxide were taken at 2, 4, 7, and 10 days. To determine carbon
dioxide evolution rates, the KOH was withdrawn from the sidearm and transferred to a clean flask. Ten ml of
fresh KOH was added to the sidearm. To the recovered KOH samples, 1 ml of saturated barium chloride and
0.1 ml of phenolphthalein were added to measure the carbon dioxide trapped in the sidearm KOH. 10 ml of
stock KOH was used at each time point as a control. The KOH solutions were titrated with 0.05 N HCl until
the solution turned from pink to colorless. The volume of HCl needed to neutralize the retrieved KOH was
recorded in milliliters. The following equation from [63] was utilized to determine the milligrams of CO2
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evolved at each time point:
CO2 (µmol) = (VC − VE) x 25 (4)
VC = volume to titrate control KOH (ml)
VE = volume to titrate experimental KOH (ml)
Amount carbon (mg) = CO2(µmol)× 10
−6mol
1 µmol
× 12.01 g C
1 mol
× 1000 mg × 0.27 (5)
For data collection, milligrams of carbon dioxide evolved versus time was determined for each sediment
culture. CO2 evolution is significant to ascertain if microorganisms are utilizing the antibiotic substrate as
their sole carbon source. The amount of carbon dioxide evolved was determined at each time point of potas-
sium hydroxide retrieval and titration using equation (4). The amount of carbon was calculated using equation
(5). For each substrate, the percent carbon was calculated by dividing the molecular weight of the substrate
by the molecular weight of all carbons in the compound (6).
Percent Carbon of Substrate =
MW of Substrate
(Number of Carbons×MW of Carbon)
MW =Molecular Weight (grams/mole)
(6)
The amount of available carbon for carbon dioxide evolution was computed for each concentration of sub-
strate by multiplying the percent carbon by the concentration of substrate using equation (7).
Milligrams Available Carbon = Percent Carbon× Concentration of Substrate (7)
The percent of carbon evolved was calculated for each time point by dividing the amount of carbon dioxide
evolved by the milligrams of available carbon and multiplying by 100 using equation (8).
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Percent Carbon Evolved =
Amount Carbon
Milligrams Available Carbon
× 100 (8)
Isolates enriched on lomefloxacin did not pass the growth analysis experiment; therefore these isolates
were not utilized to measure biodegradation (Figure 4.1, 4.2). Isolates from Hemlock Lake did not pass the
growth analysis.
2.8 Degradation of alternative substrates from sediment by robust isolates
Microbial isolates from selective antibiotic cultures were further analyzed for the ability to use alternative
substrates as a carbon source. Biodegradation methods as mentioned previously were applied in alternative
substrate analysis. Though, rather than measuring isolate CO2 evolution of selective antibiotic, varying
classes of antibiotics were analyzed for microbial biodegradation capacity by microbes enriched on selective
antibiotics.
Bioassays were created by the addition of 1.0 ml of resuspended cells and 1.0 ml antibiotic stock (6250
µg/ml amoxicillin, 1250 µg/ml chloramphenicol, and 500 µg/ml tetracycline) to the biometer flask with 48
ml of Bushnell Haas. For erythromycin and levofloxacin, 1.0 ml of resuspended cells, 3.0 ml antibiotic stock
(12500 µg/ml and 25000 µg/ml), and 46 ml of Bushnell Haas were combined, resulting in concentrations of
37500 µg/ml and 75000 µg/ml, respectively. Flasks for trimethoprim degradation involved the addition of
2.0 ml of antibiotic stock (2500 µg/ml) and 1.0 ml of resuspended cells into the flask containing 47 ml of
Bushnell Haas, giving a resulting concentration of 5000 µg/ml.
At 2, 4, 7, and 10-days, KOH was recovered from the sidearm with a syringe and titrated in a new flask
with HCl. Fresh KOH was added to the biometer flask and re-incubated at room temperature until the next
time point.
2.9 Antibiotic susceptibility testing
Enriched sediment isolates and unenriched water and sediment colonies were isolated by T-streak and then
inoculated into 125 ml Erlenmeyer flasks containing 10 ml nutrient broth for 48 hours shaking at 120 rpm,
room temperature, respectively. After 48 hours, isolates were swabbed onto Mueller Hinton agar using sterile
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cotton swabs, and the antibiotics were dispensed onto the surface. In total, 24 different antibiotics were tested
using the disc diffusion method. Table A.15 lists the 24 antibiotics used. Plates were incubated at room
temperature for 48 hours, and the diameter of the zone of inhibition (ZOI) was measured. Antimicrobial
susceptibility was determined by comparing ZOI values with Table A.15 [64].
NR
NC ×NA × 100 = % resis tan ce of colonies and antibiotics
NR = count of resis tan ce observed over multiple isolates and antibiotics in class
NC = number of colonies considered
NA = total number of antibiotics in class
(9)
Equation (9) was used for the analysis of antibiotic resistance. Each antibiotic was grouped into their
respective class as indicated in Table A.7. The resistance of varying counts of multiple colonies was observed
for each site. The count of observed resistance for a single sampling site was totaled including all isolates
and all antibiotics within each class (NR). This count was divided by the number of observed isolates (NC)
and multiplied by the number of antibiotics considered for resistance (NA). This value was multiplied by 100
to obtain the percent resistance of colonies to various antibiotics within each class from each sampling site.
2.10 Classification of robust heterotrophs
Unknown samples 1-7 were streaked onto R2A nutrient media, incubated for 48 hours at 22± 2◦C, then eval-
uated for colony morphology and pigmentation. Gram’s method was performed using the usual modus operandi
(m.o.) to classify unknown bacteria.
The following m.o. was followed to perform Gram’s method. A coin-sized circle was applied to the glass
microscope slide using a wax crayon. Next, a loopful of deionized water (DI H2O) was retrieved with a sterile
inoculating loop and placed inside the circle on the microscope slide. With a sterile disposable inoculating
loop, a small amount of the isolated colony was smeared evenly onto the glass slide. Following air drying
of the isolate and DI H2O, the slide was heat fixed with a Bunsen burner. Crystal violet was then applied
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to the slide for 60 seconds, then rinsed off with DI H2O. Next, Gram’s iodine was poured over the slide for
an additional 60 seconds, then rinsed again with water. Ethanol then flooded the slide for 5-10 seconds and
was rewashed with water. Finally, safranin was applied to the slide for 40-60 seconds, rinsed with water, and
then blotted with bibulous paper. Following the gram-stain procedure, slides were examined under 10x, 40x,
and 100x objective lenses using a Bausch & Lomb Galen III binocular compound microscope. Isolates were
photographed under 1000x immersion oil.
2.11 Statistical analysis
A two-way analysis of variance (ANOVA) was used to evaluate if the number of culturable heterotrophic
microorganisms were statistically different between the sampling site and season. The response was either
water or sediment viable cell counts (CFU/ml) totaling a set of 30 samples. The fixed factors for the evaluation
were sampling location with five levels (Charlotte, Durand, Genesee, Hemlock, and Payne) and season with
two levels (summer and fall). Sampling size was equal to 3 (n=3) for triplicates performed from each sample
location. Statistical analyses were performed using IBM SPSS software.
Chapter 3
Site comparison
3.1 Overview
In an attempt to gather microbiological information about the environment by which bacteria capable of
biodegradation originate from, isolation and enumeration of heterotrophic plate count (HPC) bacteria from
contaminated and uncontaminated sampling sites was performed. Heterotrophic bacteria are widely used as
a measure of drinking water quality [20].
We found that season and sampling site significantly impacted the amount of HPC bacteria in water and
sediment samples. We propose the negative effect effluent discharge has on water quality and the importance
of water body volume in contaminant risk assessment.
3.2 Results
3.2.1 Geospatial analysis of WWTPs
Figure 3.1 shows the proximity of major DMR facilities within 1, 5, and 10-mile buffers around the Charlotte
sampling site. Within the 5 mile buffer, Charlotte receives wastewater discharge from Eastman Business
Park and Frank E Van Lare WWTP. Just outside the 5-mile buffer is the RG&E Beebee Station. It is worth
mentioning that Eastman Business Park and the RG&E Beebee Station are in the HUC 8 watershed where
the Charlotte samples were obtained, therefore draining of these facilities would have a direct impact on
Charlotte Beach. Of all the sites within this study, Charlotte Beach likely receives the highest amount of
wastewater discharge pollution. Wastewater information was collected using the U.S. EPA ECHO pollutant
loading tool for 2017 Discharge Monitoring Report (DMR) [59] (Table A.3).
Within the 1 mile buffer of Durand Beach is the Frank E Van Lare WWTP (Figure 3.1). Durand Beach is
19
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also significantly impacted by Eastman Business Park (5 miles) and Rochester Gas and Electric Corporation
(RG&E) Beebee Station effluent between 5 and 10 miles from the site. In addition to the Van Lare WWTP,
the HUC 8 region (04140101) also contains Walter W Bradley Water Pollution Control Facility (WPCF) just
outside the 10-mile buffer region.
POI
Charlotte
Durand
Payne
Major DMR Facility
Northwest Quad Pw Dist#1
Frank E Van Lare WWTP
Eastman Business Park
RG&E Beebee Station
POI
Charlotte
Durand
Major DMR Facility
Frank E Van Lare WWTP
Walter W Bradley WPCF
Eastman Business Park
RG&E Beebee Station
0 5 103 Miles 0 5 103 Miles
HUC 8
04130001
04130003
04140101
04140201
04150200
02050105
04130002
Figure 3.1: Major WWTPs within 10 miles from Charlotte (left) and Durand (right)
Wastewater discharge facilities do not as substantially impact the Genesee River as the other sampling
locations. Just beyond the 5-mile buffer and within the HUC 8 watershed (04130003) is the Avon sewage
treatment plant (STP) (Figure 3.2). It is notable that the Genesee River flows from South to North into Lake
Ontario.
Hemlock Lake is used as a drinking water source and at approximately 10 miles out is Conesus Lake
County Sewer District (Figure 3.2), within the HUC 8 watershed boundary (04130003).
Payne Beach is near Braddock Bay Bird Observatory. This sampling site is directly where the North West
Quadrant (NWQ) WWTP effluent pipe is situated. In addition to the NWQ WWTP located within 1 mile of
the site, Spencerport WWTP and Eastman Business Park are located just outside the 10-mile buffer as shown
in Figure 3.3.
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Figure 3.2: Major WWTPs within 10 miles from Genesee (left) and Hemlock (right)
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Figure 3.3: Major WWTPs within 10 miles from Payne Beach
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3.2.2 Bacterial populations
The highest summer water sample cell counts were from Durand (8.33x105) and Payne (2.20x106) (Ta-
ble A.1). The lowest summer water sample viable cell counts were from Hemlock (1.67x105), Charlotte
(2.00x105), and Genesee (3.00x105) (Figure 3.4 and Table 3.1a). In contrast, fall water samples were highest
from Genesee (5.62x107) and Hemlock (5.82x107). The lowest fall water viable cell counts were cultured
from Durand (7.33x105), Charlotte (8.00x105), and Payne (8.67x105).
Summer sediment mean CFU/ml was highest from Genesee (2.59x107) and Payne (1.03x107) (Figure
3.5 and Table 3.1b). The lowest summer sediment viable cell counts were observed in samples obtained
from Charlotte (1.43x106), Durand (1.47x106), and Hemlock (4.77x106). Similar in comparison to the high-
est mean viable cell counts among triplicates from fall water samples, fall sediment CFU/ml was highest
from Genesee (2.85x107) and Hemlock (7.77x107). Among the sampling sites with the lowest fall sediment
CFU/ml were Charlotte (1.30x106), Payne (1.60x106), and Durand (7.27x106).
Figure 3.4: Viable cell counts of water cultures
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The above figure presents the triplicate means of culturable water isolates measured in colony forming units
at ten days. Error bars: ±1 SE.
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Figure 3.5: Viable cell counts of sediment cultures
Season
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The above figure presents the triplicate means of culturable sediment isolates measured in colony forming
units at ten days. Error bars: ±1 SE.
Table 3.1: Viable cell counts of water and sediment
(a) Water
Site Fall Summer
Charlotte 8.00x105 2.00x105
Durand 7.33x105 8.33x105
Genesee 5.62x107 3.00x105
Hemlock 5.82x107 1.67x105
Payne 8.67x105 2.20x106
(b) Sediment
Site Fall Summer
Charlotte 1.30x106 1.43x106
Durand 7.27x106 1.47x106
Genesee 2.85x107 2.59x107
Hemlock 7.77x107 4.77x106
Payne 1.60x106 1.03x107
3.2.3 Effect of sampling site and season on water bacterial populations
A two-way ANOVA analysis was conducted on viable cell counts from water samples to determine if it was
season or site that was impacting CFU/ml or both of these factors. Season, fall and summer, has a significant
effect on culturable heterotrophs in water (Table A.1). The F distribution of season was calculated to be: F(1,
20) = 3020.5, and with 95% (p < 0.05) confidence, we reject the null hypothesis that season will have no
significant effect on water counts as the F-value is far greater than the critical value of the distribution.
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Moreover, the F distribution of sampling site (F(4,20) = 1094.4) allowed the rejection of the null hypoth-
esis that the site will have no significant effect on counts. For season and sampling site (F(4, 20) = 1161.9,
p < 0.05), we accept the alternative hypothesis that season and site interaction have a significant effect on
heterotrophic, culturable colony forming units per milliliter in water.
3.2.4 Effect of sampling site and season on sediment bacterial populations
Sediment heterotroph colony counts were also analyzed for the impacts of season and site on counts, both
separately and together. The analysis of our results indicate that with 95% confidence, sampling site has a
significant effect (F(4, 20) = 49.4, p < 0.05) on culturable microbes in sediment (Table A.2). The F distribution
of season (F(1, 20) = 42.9, p < 0.05) by which samples were obtained and further cultured from, indicates
that this factor has a significant effect on CFU/ml in sediments of Western New York. Jointly, both site and
season have a significant impact on sediment counts. F-values indicate that, for sediment samples, the site
has a greater impact on colony counts than that of season and site together or season alone.
For water viable cell counts (CFU/ml), a Tukey honest significance test (HSD) test revealed that Gene-
see and Hemlock presented significantly higher cell counts than Charlotte, Durand, and Payne, respectively
(Table A.10). For sediment HPC analysis, a Tukey HSD test illustrated that with 95% confidence, Hemlock
varied significantly from Genesee, Payne, Durand, and Charlotte (Table A.11). We conclude that there is a
huge variability of water and sediment colony counts across space and time.
3.3 Discussion
3.3.1 Importance of water body volume when assessing effluent discharge
Between 2015 to 2017, Charlotte Beach received 36.3, 67.2, and 3.88 million, totaling approximately 107
million, pounds of pollutants in wastewater effluent from the Frank E. Van Lare WWTP, Kodak, and the
NWQ WWTP, respectively (Table A.3). These facilities exceeded effluent guidelines by over 1.6 million
pounds. During the same period, Durand Beach received the highest amount of wastewater effluent, of over
115 million pounds from the nearest facilities: Van Lare, Walter Bradley, Kodak, and Xerox. The third highly
polluted sampling site with wastewater effluent was Payne Beach, which was calculated to receive about 71
million pounds of pollutants from the NWQ WWTP and Kodak. Hemlock Lake acquired approximately 206
thousand pounds of contaminants from Consensus Lake Sewer District and Hemlock Water Filtration Plant,
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whereas the Genesee River was calculated to have the least amount of effluent pollution at just 55 thousand
pounds from Avon STP and Leroy WWTP.
Effluent discharge between 2015 and 2017 suggests that water quality should descend in condition from
Genesee > Hemlock > Payne > Durand > Charlotte. The counts of heterotrophs are used as a measure of
water quality [20]. Our studies indicate that there is an overlooked factor influencing water quality at these
sampling sites.
One would expect the water quality at Charlotte to be lesser than that of Hemlock, due to observations in
effluent discharge from the adjacent facilities. Though, this is not the case, as we recorded a lower quantity of
heterotrophs from Charlotte Beach (Lake Ontario) than Hemlock Lake. Our results indicate that water volume
plays a significant role in water quality as wastewater effluent and other water pollutants would theoretically
be more diluted in higher volumes of water.
One of the Great Lakes, Lake Ontario, has a maximum depth of 244 meters and the volume was computed
to be 392.23 miles3 (1.64x1015 liters) by using information on the water area and average depth [65]. On the
other hand, one of the Finger Lakes, Hemlock Lake has a maximum depth of 28 meters [66] with an estimated
water volume of 0.025 miles3 (1.04x1011 liters).
We observed elevated HPCs from Hemlock Lake, likely as a result of higher pressure exerted by wastew-
ater effluent due to lesser water volume. Our study indicates that when determining impacts on water quality,
water body volume is an essential factor that must not be ignored.
3.4 Conclusion
Firstly, we found that HPC bacteria varied by season in both water and sediment samples. This notion is
supported by a study from the Missouri River, where water HPC bacteria were found to be significantly higher
in the summer in comparison with the winter [67]. This study supports their findings, and as [67] indicate, we
also suggest measuring drinking water contamination by HPC counts under low-temperature conditions as
the season is proven to have a dominant effect on indicator bacteria. We hypothesize the negative, dominant
effect wastewater effluents exert on freshwater, natural ecosystems of Western New York and the significance
of water volume when determining water quality.
Chapter 4
Biodegradation
4.1 Overview
Heterotrophs were isolated from the waters of Western New York in an attempt to heighten the understanding
of their metabolic characteristics. Microbial acclimation to antibiotic substrates was examined in terms of
1) carbon supply, and 2) alternative substrates. We propose that microbial degradation capacity is limited
by organic carbon substrate availability and maximized by alternative substrate presence, the latter of which,
binding affinities were augmented.
4.2 Results
4.2.1 Enumeration of enrichment cultures
Enrichment 3 was enumerated in an attempt to culture heterotrophic microorganisms capable of thriving in
high concentrations of a particular pharmaceutical. Quite a few summer sediment enrichments were observed
with no growth when plated onto R2A media (Figure 4.1), despite turbidity presence in enrichment 3 (Table
A.12). These bacteria were cultured from Hemlock, Genesee, and Charlotte enriched on ampicillin; Hemlock,
Charlotte, and Durand enriched on streptomycin; and Genesee enriched on lomefloxacin (Table 4.1). In
contrast, fall sediment enrichment viable cell counts only exhibited no growth for Durand culture enriched on
lomefloxacin (Table 4.2), of which, visual qualifications of turbidity can be observed in Table A.13. It must
be considered that dead cells can make a culture appear turbid [68].
Of the summer enrichment cultures, particular sampling locations were ranked with the highest colony
counts for particular pharmaceuticals. Out of all other sampling locations, Durand was detected to have the
highest viable cell counts when enriched on ampicillin (2.60x108) and cefepime (1.00x108), respectively.
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Figure 4.1: Summer viable cell counts after 21-day enrichment
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Figure 4.2: Fall viable cell counts after 21-day enrichment
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Lomefloxacin enrichment counts were the highest from Charlotte (2.00x107) and streptomycin enrichment
counts were only documented from Payne (4.60x108) (Figure 4.1).
Charlotte sediment culture enriched on lomefloxacin (1.20x109) was predicted to have the highest viable
cell counts for fall enrichments (Figure 4.2). Out of all other sampling locations from fall enrichments on
ampicillin, Payne displayed the highest viable cell counts (1.30x108). Fall enrichments on cefepime produced
the most significant quantity of bacteria from Genesee culture (4.10x108). Similar to summer enrichment
viable cell counts, fall enrichment on lomefloxacin from Charlotte had the highest counts (1.20x109) out of
all sampling location lomefloxacin enrichments. Similar to summer enrichment counts, the fall enrichment
on streptomycin was the highest from Payne sediment culture (2.40x108).
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Table 4.1: Growth of isolates on substrates used for selection
(a) Summer
Growth substrate Unknown k (days-1)
Ampicillin 6 0.22
23 NG
24 NG
Cefepime 7 0.16
25 NG
26 NG
Lomefloxacin 27 NG
28 NG
29 NG
30 NG
Streptomycin 5 0.17
31 NG
32 NG
33 NG
34 NG
35 0.06
(b) Fall
Growth substrate Unknown k (days-1)
Ampicillin 1 0.21
8 0.14
9 0.21
10 0.18
Cefepime 2 0.19
3 0.25
4 0.25
11 0.11
12 0.06
13 0.08
14 NG
15 0.16
Lomefloxacin 16 NG
17 NG
18 0.07
Streptomycin 19 0.16
20 0.03
21 0.20
22 0.21
4.2.2 Growth of acclimated bacteria on substrates for the determination of robustness
The growth rate (k) of enrichment summer isolates can be observed in Table 4.1a. Isolates formerly enriched
on cefepime from Durand and Charlotte Beaches were capable of rapid cell division in the presence of
cefepime. In the presence of cefepime, unknown 2 had a growth rate of 0.19 day-1, whereas unknown 4 was
able to divide at a rate of 0.25 day-1. Unknown 3 isolate from Charlotte was capable of growing as fast as
0.25 day-1. Durand unknown 1 isolate, initially enriched on ampicillin, was able to grow at a rate of 0.21
day-1.
Fall growth rates from enrichment isolates are organized in Table 4.1b. Unknown 5 from Durand grew at
a rate of 0.17 day-1 on streptomycin, unknown 6 from Payne grew at 0.22 day-1 on ampicillin, and unknown
7 from the Genesee River grew at 0.16 day-1 on cefepime. Isolates with high growth rates and short doubling
times were deemed robust and chosen for further experimentation.
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4.2.3 Growth of robust isolates on alternative substrates
Table 4.2 illustrates the growth rate (k) of robust fall and summer unknowns on alternative antibiotic sub-
strates. These selected isolates were originally enriched on a single antibiotic and chosen for further analysis
with different classes of antibiotics.
Unknown Alternative substrate k (days-1)
1 Ampicillin 0.10
Cefepime 0.07
Chloramphenicol† 0.25
Tetracycline 0.16
2 Amoxicillin† 0.18
Cefepime† 0.18
Chloramphenicol 0.11
Trimethoprim 0.20
3 Cefepime 0.24
Erythromycin† 0.28
Levofloxacin 0.24
Tetracycline 0.10
4 Cefepime 0.10
Erythromycin 0.08
Levofloxacin NG
Tetracycline† 0.27
5 Amoxicillin† 0.15
Erythromycin 0.12
Levofloxacin NG
Streptomycin 0.12
6 Ampicillin† 0.24
Erythromycin NG
Levofloxacin NG
Trimethoprim 0.23
7 Cefepime NG
Erythromycin NG
Levofloxacin NG
Trimethoprim† 0.02
k, growth rate; †, best substrate.
Table 4.2: Growth of robust isolates on alternative
substrates
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Each unknown summer isolate used for further alternative substrate growth analysis grew best on a partic-
ular pharmaceutical. Unknown 1 further enriched on chloramphenicol had a growth rate of 0.25 day-1 (Table
4.2). Unknown 2 had the highest growth rates on amoxicillin and cefepime, each at a rate of 0.18 day-1.
Unknown 3 grew best on erythromycin, with a growth rate of 0.28 day-1. Lastly, unknown 4 achieved the
highest growth rate on tetracycline at 0.27 day-1.
Unknown 5, formerly enriched on streptomycin, had the highest growth rate on amoxicillin at 0.15 day-1.
Unknown 6, initially enriched on ampicillin accomplished the highest growth rate on the antibiotic it was
initially enriched on, ampicillin at 0.24 day-1 and secondly on trimethoprim at 0.23 day-1. Unknown 7,
formerly enriched on cefepime, only attained a growth rate with trimethoprim at 0.02 day-1, but no growth
rate was detected for the other enriched antibiotics.
Unknown 3 was the strongest isolate capable of co-existing with cefepime at 0.24 day-1, erythromycin at
0.28 day-1, and levofloxacin at 0.24 day-1. The next strongest isolate was unknown 6, being the best unknown
to co-exist with ampicillin at 0.24 day-1 and trimethoprim at 0.23 day-1. Furthermore, optimal co-existing
between unknown and antibiotic was observed as follows: unknown 1 with chloramphenicol at 0.25 day-1;
unknown 2 with amoxicillin at 0.18 day-1; unknown 4 with tetracycline at 0.27 day-1; and unknown 5 with
streptomycin at 0.12 day-1.
4.2.4 Degradation of antibiotics from soil by robust isolates
The biodegradation of ampicillin at one, two, and three-fold concentrations by unknown 1 was calculated to
be 33.3%, 16.3%, and 13.0%, respectively (Table 4.3, Figure B.10). Unknown 6 attained a similar degradation
pattern of ampicillin at 27.0% of 7.5 mg, 13.4% of 15 mg, and 11.9% of 22.5 mg (Table 4.4, Figure B.15).
Ampicillin biodegradation measured during the summer and fall at 7.5 mg, 15 mg, and 22.5 milligrams
showed similar patterns of degradation as did cefepime.
Cefepime biodegradation was assessed with unknowns 2, 3, 4, and 7. Unknown 2 was capable of reme-
diating 7.5, 15, and 22.5 milligrams of cefepime from sediment by 42.1%, 24.0%, and 15.9%, independently
(Table 4.3, Figure B.11). Cefepime degradation by unknown 4 exhibited similar patterns as other unknowns
with degradation capacity being 20.6% of 7.5 mg, 18.9% of 15 mg, and 5.7% of 22.5 mg (Figure B.13).
Streptomycin biodegradation of 10 mg, 20 mg, and 30 milligrams achieved similar patterns of degradation
as did ampicillin and cefepime. Unknown 5 was capable of degrading 18.1% of 10 mg, 17.8% of 20 mg, and
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Unknown Original Substrate Mol Wt ρ C avail. CO2 evol. Deg. (%)
1 Ampicillin 349.4
7.5 4.12 1.37 33.3
15 8.25 1.35 16.3
22.5 12.38 1.61 13.0
2 Cefepime 480.6
7.5 3.56 1.50 42.1
15 7.05 1.69 24.0
22.5 10.58 1.68 15.9
3 Cefepime 480.6
7.5 3.56 1.09 30.6
15 7.05 1.01 14.3
22.5 10.58 1.93 18.2
4 Cefepime 480.6
7.5 3.56 0.74 20.6
15 7.05 1.33 18.9
22.5 10.58 0.61 5.7
ρ, concentration of antibiotic substrate in mg/ml; CO2 evol., total cumulative carbon diox-
ide evolved at 10 days; C avail., available carbon in sample; Deg. (%), total degradation
percentage.
Table 4.3: CO2 evolution of summer unknowns with substrates used in selection
13.8% of 30 mg streptomycin (Table 4.4, Figure B.14).
It must be mentioned that there were some instances where increasing the antibiotic concentration past
a certain threshold proved to stimulate antibiotic degradation, suggesting an optimal concentration at which
antibiotics are more readily biodegraded in sediments. For instance, Charlotte summer isolate (unknown
3) degraded 30.6% of 7.5 mg, 14.3% of 15 mg, and 18.2% of 22.5 mg (Table 4.3, Figure B.12). Similarly,
degradation of cefepime was optimized in fall Genesee isolate originally enriched on cefepime as the microbe
degraded 18.7% of 7.5 milligrams, 14.9% of 15 milligrams, and 17.4% of 22.5 milligrams (Table 4.4, Figure
B.16).
4.2.5 Degradation of alternative substrates from soil by robust isolates
Robust isolates selected for in antibiotic amended cultures were further analyzed for metabolism of alterna-
tive antibiotic substrates. Unknown 1 was able to degrade 28.65% of 3.56 mg cefepime, 49.28% of 0.51
mg chloramphenicol, and 70.26% of 0.30 mg tetracycline (Table 4.5, Figure B.17). Unknown 2 was able
to degrade 40.16% of 3.29 mg amoxicillin, 66.76% of 0.51 mg chloramphenicol, and 55.94% of 5.0 mg
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Unknown Original Substrate Mol Wt ρ C avail. CO2 evol. Deg. (%)
5 Streptomycin 581.8
10 4.3 0.8 18.1
20 8.7 1.5 17.8
30 13 1.8 13.8
6 Ampicillin 349.4
7.5 4.1 1.1 27.0
15 8.3 1.1 13.4
22.5 12.4 1.5 11.9
7 Cefepime 480.6
7.5 3.6 0.7 18.7
15 7.1 1.1 14.9
22.5 10.6 1.8 17.4
ρ, concentration of antibiotic substrate in mg/ml; CO2 evol., total cumulative carbon diox-
ide evolved at 10 days; C avail., available carbon in sample; Deg. (%), total degradation
percentage.
Table 4.4: CO2 evolution of fall unknowns with substrates used in selection
trimethoprim (Figure B.18). Unknown 3 was able to degrade 2.42% of 22.7 mg erythromycin and 1.38%
of 44.87 mg levofloxacin (Figure B.19). Unknown 4 was able to degrade 6.13% of 22.7 mg erythromycin,
1.13% of 44.87 mg levofloxacin, and 72.96% of 0.30 tetracycline (Figure B.20).
Unknown 5 degraded 18.25% of 3.29 mg amoxicillin, 9.39% of 22.7 mg erythromycin, and 1.05% of
44.87 mg levofloxacin (Table 4.6, Figure B.21). Unknown 6, originally enriched on ampicillin, was able to
degrade 6.39% of 22.7 mg erythromycin, 1.25% of 44.87 mg levofloxacin, and 57.22% of 2.90 mg trimetho-
prim (Figure B.22). Unknown 7, originally enriched on cefepime, was able to degrade 9.75% of 22.7 mg
erythromycin, 2.46% of 44.87 mg levofloxacin, and 54.51% of 2.90 mg trimethoprim (Figure B.23).
4.3 Discussion
4.3.1 Out-competition of native bacteria by culture enrichment
The enrichment of sediments on a particular antibiotic was shown to promote the growth of heterotrophs in
summer and fall. Through the growth of sediments with a selective antibiotic, microbes that did not confer
resistance were selected against thereby allowing resistant microbes to thrive in the culture. This is confirmed
through the comparison of viable cell counts in sediment (Figure 3.5) with the enrichment viable cell counts
(Figure 4.1, 4.2). It is noticeable that fall viable cell counts were much higher after enrichment than that of
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Unk. Original Substrate Alternative Substrate Mol Wt ρ CO2 evol. C avail. Deg. (%)
1 Ampicillin
Cefepime 480.6 6.25 1.02 3.56 28.65
Chloramphenicol 323.1 1.25 0.25 0.51 49.28
Tetracycline 444.4 0.50 0.21 0.30 70.26
2 Cefepime
Amoxicillin 365.4 6.25 1.32 3.29 40.16
Chloramphenicol 323.1 1.25 0.34 0.51 66.76
Trimethoprim 290.3 2.90 1.62 5.0 55.94
3 Cefepime
Erythromycin 733.9 37.5 0.55 22.7 2.42
Levofloxacin 361.4 75.0 0.62 44.87 1.38
4 Cefepime
Erythromycin 733.9 37.5 1.39 22.7 6.13
Levofloxacin 361.4 75.0 0.51 44.87 1.13
Tetracycline 444.4 0.50 0.22 0.30 72.96
Unk., unknown isolate; ρ, concentration of antibiotic substrate in mg/ml; CO2 evol., total cumulative carbon
dioxide evolved at 10 days; C avail., available carbon in sample; Deg. (%), total degradation percentage.
Table 4.5: CO2 evolution of summer isolates with alternative substrates
Unk. Original Substrate Alternative Substrate Mol Wt ρ CO2 evol. C avail. Deg. (%)
5 Streptomycin
Amoxicillin 365.4 6.25 0.60 3.29 18.25
Erythromycin 733.9 37.5 1.91 22.7 9.39
Levofloxacin 361.4 75 0.47 44.87 1.05
6 Ampicillin
Erythromycin 733.9 37.5 1.45 22.7 6.39
Levofloxacin 361.4 75 0.56 44.87 1.25
Trimethoprim 290.3 5 1.66 2.90 57.22
7 Cefepime
Erythromycin 733.9 37.5 2.21 22.7 9.75
Levofloxacin 361.4 75 1.10 44.87 2.46
Trimethoprim 290.3 5 1.58 2.90 54.51
Unk., unknown isolate; ρ, concentration of antibiotic substrate in mg/ml; CO2 evol., total cumulative carbon
dioxide evolved at 10 days; C avail., available carbon in sample; Deg. (%), total degradation percentage.
Table 4.6: CO2 evolution of fall isolates with alternative substrates
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summer.
Enumeration of sediment enrichments with ampicillin, cefepime, lomefloxacin, or streptomycin illus-
trated that the exposure of natural water sources to high concentrations of pharmaceutical induces the selec-
tion of microbes with the ability to survive in these highly polluted environments through natural selection.
In some instances, enrichment of culture resulted in higher viable cell counts than that of un-amended cul-
tures. This result suggests these sampling sites receive high concentrations of specific pharmaceuticals from
wastewater effluents as microbes within the sample were capable of survival following exposure.
As anticipated, summer cell counts of Payne Beach increased from 1.03x107 in un-amended cultures
to 4.6x108 CFU/ml in streptomycin enrichment cultures (Figure 3.5; Figure 4.1). On the other hand, the
enrichment of Payne Beach sediment to cefepime and lomefloxacin resulted in approximately the same viable
cell counts in enriched and un-amended cultures for summer, while ampicillin enrichments resulted in a
complete loss of colony counts. This outcome suggests that there may be little to no ampicillin being released
into Payne Beach or that there is a microbial self-cleansing process at work within these sediments. Payne
Beach receives wastewater effluent from the Northwest Quadrant WWTP and droppings from migratory birds
that find refuge at Braddock Bay Bird Observatory [57], [58].
It was surprising that Hemlock Lake sediments presented the highest amount of viable cells (7.77x107
CFU/ml) in fall and the third highest (4.77x106) in summer, as this site is used as drinking water (Figure 3.5).
Despite the high number of cells present on R2A media, enumeration of enrichment cultures revealed that
Hemlock likely does not receive high concentrations of pharmaceuticals as naturally occurring colonies were
unable to survive and were not out-competed by the exposure to high concentrations (Figures 4.1 and 4.2).
It is important to note that summer enrichment of culture on cefepime resulted in approximately the same
amount of culturable microbes as un-amended cultures. This case suggests that these microbes can survive
in the presence of cefepime due to resistance genes occurring from possible metal or antibiotic exposure
through effluents. The exposure of natural environments to heavy metals has been observed in prior studies
to facilitate the resistance of antibiotics [69]. Hemlock Lake may receive high concentrations of cefepime
from Consensus Lake County Sewer District which is located within 10 miles from the water body.
It is notable to mention that in fall, the exposure of Charlotte Beach sediments to ampicillin, cefepime,
lomefloxacin, and streptomycin, respectively, over 21-days resulted in a significant increase in viable cell
counts from 1.3x106 CFU/ml in un-enriched sediment cultures (Figure 3.5) to 1.1x108, 2.6x108, 1.2x109,
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and 1.7x108 CFU/ml in enriched cultures, respectively (Figure 4.2). These results suggest that Charlotte
Beach receives high concentrations of ampicillin, cefepime, lomefloxacin, and streptomycin as there were
microbes present in the culture that was able to withstand extremely high concentrations of antibiotic. Char-
lotte Beach receives wastewater that is deposited into the Genesee River which flows from south to north into
Lake Ontario. Charlotte Beach is located directly to the west of the Genesee River mouth. Before outflow-
ing into Lake Ontario, the Genesee receives medical wastewater effluents from Rochester Regional Health
and Highland Hospital. Additionally, Charlotte receives effluents from Van Lare WWTP, Kodak (Eastman
Business Park), and RG&E Beebee Station. There may be a significant release of ampicillin, cefepime, lome-
floxacin, and streptomycin into Charlotte Beach, resulting in high amounts of bacteria capable of using these
compounds in sediment.
The enrichment of culture sampled from Durand Beach with ampicillin, cefepime, or lomefloxacin in-
creased the number of heterotrophs in comparison with un-enriched culture (1.47x106) in summer and
(7.27x106) fall (Figures 3.5, 4.1, and 4.2). These results suggest that Durand Beach receives significantly
higher concentrations of ampicillin, cefepime, and lomefloxacin than the other sampling sites. It is possible
that Durand may receive elevated concentrations of these pharmaceuticals from wastewater effluents on the
southeastern coast of Lake Ontario, such as Walter W. Bradley WPCF. Additionally, Durand receives effluents
from Van Lare WWTP and may be impacted by Kodak and RG&E effluents that outflow into Charlotte Beach
and may make way to Durand which is located to the east. The observation of the variability between seasons
in the number of microorganisms able to survive after enrichment suggests that microbes in the environment
can restore themselves to normal over many generations (Figures 4.1 and 4.2). This assumption suggests that
microbes may undergo loss of ARGs over time if antibiotic concentrations are reduced in the environment
either through biodegradation or lessened environmental exposure through effluents. These results may point
to the solution that increased efficiency of removal of pharmaceuticals from effluents may quickly reverse
antibiotic resistance observed in the environment.
4.3.2 Growth promotion with antibiotic substrates
Colonies were isolated from enriched cultures, and the growth on pharmaceuticals used for selection and on
alternative antibiotics was assessed. The growth analysis was performed to narrow down microbes with the
potential to use specific antibiotics as their sole carbon source. The growth of summer isolates on selected
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antibiotics was significantly more successful than fall enriched isolates, suggesting differences in the micro-
bial composition of sampling sites. This difference may be attributed to the fact that summer samples were
obtained in odd locations as regular sites were inaccessible due to flooding. A wide variety of heterotrophs
were able to withstand growth on selected antibiotics and alternative antibiotics. This observation suggests
that the exposure to high concentrations of a single pharmaceutical compound would inevitably enable the
survivability and growth of microbes with alternative antibiotics. The ability of microbes to grow with an-
tibiotics may have a direct link with high concentrations of antibiotics in wastewater effluents released into
surface waters that make way into sediments by the settling of compounds. Isolates with a short doubling
time and high growth rate were chosen for further analysis on their ability to remove these substrates from
the environment through degradation experiments.
4.3.3 Limitation of available carbon on biodegradation
Prior studies indicate that environmental exposure to chemicals may induce the biodegradability of these
compounds due to adaptation techniques for survival [70]. Microbes capable of sufficient growth with an-
tibiotics from Charlotte, Durand, Genesee, and Payne were used for degradation experiments. Isolates from
Hemlock Lake did not grow well with the selected antibiotics, which is likely a result of little to no effluent
containing antibiotics being emitted into the lake. Conversely, the successful growth of microbes with antibi-
otics from the other four sampling sites suggests that pharmaceuticals in wastewater effluents may play a role
in the ability of microbes to survive in highly polluted environments and further their ability to degrade such
compounds.
In particular, several isolates from Durand Eastman Beach were able to degrade ampicillin, cefepime,
and streptomycin. This finding suggests that wastewater effluents containing high antibiotic concentrations
may induce degradation capabilities of microbes in freshwater environments. Furthermore, the degradation
capacity was limited by available carbon. Despite the three-fold increase in the amount of available carbon
for use, heterotrophic bacteria were not able to use more (Tables 4.3 and 4.4). A prior study of dose-response
relationships by Topp, et al. 2012, observed accelerated antibiotic biodegradation in soil samples exposed
to 0.01 µg/ml in comparison with 1.0 x 10-4 µg/ml of sulfamethazine [71]. Our findings suggest that the
microbial degradation of antibiotics is optimized at a unique concentration and varies for each microbe-
chemical relationship.
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Findings suggest a correlation existing between wastewater effluents and degradation abilities of het-
erotrophs in the waters of Western New York. Prior studies found that isolated heterotrophs from effluent
receiving water bodies in this region were able to degrade acetaminophen and ibuprofen [63]. Moreover,
a study found the removal efficiency of ARGs between 33.30 and 97.56% [23]. This study supports those
findings while simultaneously reporting the ability of these microbes to degrade antibiotics.
Results presented in this study suggest that bacteria in highly polluted ecosystems may have the ability
to maintain homeostasis of their environment by utilizing pollutants as energy sources. These results also
indicate that antibiotic-degrading bacteria are present in freshwater sediments ex situ, though further studies
must focus on the analysis of this phenomenon in situ and then apply these findings to the treatment of
wastewater.
Metabolism of antibiotic substrates by heterotrophs was shown to be limited by available carbon biomass
concentration. Increases in total available carbon biomass from antibiotic substrates did not prove to stimulate
microbial metabolism; therefore we conclude that enzyme synthesis is dependent on the amount of antibiotic
in cultures. This finding is corroborated by prior findings from Lodge, 1980, that the assimilation of iron was
controlled by concentration [72].
We propose that increased carbon biomass limits microbial metabolism in heterotrophs cultured from
the sediment of highly polluted environments. This notion is supported by results from [73], where scientists
indicate that oxygen flux is limited by carbon biomass concentration in heterotrophs. For example, in contrast
to the low biomass concentration of 0.2 mg cm-3 Fe(III)-oxide, high biomass concentrations of 2.0 mg cm-3
were proven to decrease the net community growth rate.
4.3.4 Biodegradation augmentation using alternative substrates
Bacteria isolated from Charlotte, Durand, Genesee, and Payne was capable of growth on alternative substrates
and was further studied for their ability to remove these compounds. Alternative antibiotic substrates of vari-
ous antibiotic classes were chosen based upon known molecular differences in mechanisms of action on the
cell. Isolates selected initially for using a single antibiotic presented successful growth on other classes of an-
tibiotics from these four sampling sites, suggesting that the exposure of sediments to a single pharmaceutical
will enhance the survival and removal abilities in the presence of structurally different chemicals.
An isolate from Durand Beach was able to degrade approximately the same percentage of streptomycin,
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an aminoglycoside, as amoxicillin, a beta-lactam. Alternatively, isolates from the Genesee River and Payne
Beach showed increased removal abilities of the alternative antibiotic substrate, trimethoprim, in comparison
with the initially enriched substrate. These results suggest alternative substrates have an affinity for binding
to the enzyme involved in metabolism. Isolates cultured from Payne Beach and the Genesee River were en-
riched on a beta-lactam and a cephalosporin, respectively, which are structurally similar as these compounds
interfere with bacterial cell wall synthesis. Jayakody, Johnson, Whitman, et al. (2018) reported similar find-
ings as we present here, as an engineered microbe was able to metabolize waste carbon and bind to various
substrates [19]. These findings have significant applications in terms of valorization or reuse of toxic waste
[19].
The assimilation of other antibiotic substrates by selected heterotrophs significantly stimulates microbial
metabolism. Similarly, prior studies have indicated that various iron nutrients stimulate heterotrophic growth
[74]. Isolates exhibit heightened binding affinity to various substrates, as metabolism was limited with the
selected antibiotic substrate. Therefore, we conclude that the assimilation of antibiotics in wastewater con-
taminated environments by heterotrophs is controlled by substrate availability.
4.4 Conclusion
While antibiotics are abundant in the environment, microbial metabolism is limited by carbon-availability and
maximized by the use of alternative substrates. In other words, microbes showed expanded substrate utiliza-
tion. Prior studies have used bioengineered strains of P. putida to detoxify thermochemical (TC) wastewater
using aerobic catabolic pathways of metabolism [19]. We provide evidence of these pathways in heterotrophs
exposed to industrially-relevant drug levels.
We conclude that microbial assimilation of antibiotics in the environment is carbon-limited and weakly
substrate-specific. Increases in total available carbon biomass from antibiotic substrates did not stimulate
microbial metabolism. Metabolism of antibiotic substrates by heterotrophs is shown to be limited by available
carbon biomass concentration and maximized by alternative substrates. These results suggest these microbes
possess unusual metabolic capabilities as isolates exhibit high binding affinity to various substrates and the
enzymes involved in this process are not immensely substrate-specific.
Chapter 5
Antibiotic resistance
5.1 Overview
Samples from sites with point source pollution (Charlotte, Durand, Genesee, and Payne) were compared to
a site with used as a drinking water source (Hemlock). Firstly, water and sediment isolates were analyzed
for antibiotic resistance. Secondly, highly polluted environments were modeled in sediment samples through
21-day exposure enrichments, after which, isolates were cultured and examined for antibiotic resistance.
Most significantly, unknown isolates that were used to measure biodegradation were further analyzed for
antimicrobial susceptibility.
This study reports the antibiotic resistance of heterotrophic microorganisms isolated from these sites
which were enriched and unenriched to 24 different antibiotics. We posit that there may be a link between
antibiotic resistance and biodegradation in sediment heterotrophs of polluted freshwater environments and
that wastewater pollution increase bacterial antibiotic resistance in freshwater and sediment.
5.2 Results
5.2.1 Antibiotic resistance of water and sediment isolates
Tables 5.3 and 5.2 show the resistance of culturable heterotrophic surface water and sediment isolates. Over-
all, surface water and sediment isolates cultured in summer and fall from sites with point source pollution
(Charlotte, Durand, Genesee, and Payne) exhibited significantly higher percent antibiotic resistance across
all antibiotic classes when compared to Hemlock Lake.
Point source pollution for Charlotte is the most varied among all sources studied as it receives wastewater
from Monroe County Water Authority, Van Lare, Kodak, Highland Hospital, and Rochester Regional Health.
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Braddock Bay Wildlife Refuge is also near to Charlotte (as well as Payne). Durand Eastman Beach is approx-
imately 250 feet from Van Lare and also would receive pollutants from Webster Wastewater Treatment and
Brighton Landfill. Samples obtained from Payne Beach are directly at the location of a sewage pipe from the
NWQ Public Works. The sampling site along the Genesee River is significantly further from point sources,
such as Leroy WWTP ( 13 miles), Mill Seat Landfill ( 11.0 miles), and Water Treatment by Culligan.
Antibiotic class Charlotte Durand Genesee Hemlock Payne
Surface water
Cephalosporin 43.3 ND 9.5 0.0 58.3
Beta-lactam 37.5 ND 8.9 0.0 34.4
Fluoroquinolone 6.7 ND 9.5 0.0 16.7
Aminoglycoside 5.0 ND 3.6 0.0 12.5
Sediment
Cephalosporin 60.0 79.2 91.7 5.6 54.2
Beta-lactam 37.5 46.9 65.6 4.2 34.4
Fluoroquinolone 0.0 0.0 25.0 22.2 0.0
Aminoglycoside 95.0 25.0 37.5 0.0 12.5
Values represent the percentage of colonies resistant to antibiotics within each
class, as specified in Table A.7. Equation (9) was used to obtain percentages.
ND, not determined as no isolates were cultured.
Table 5.1: Fall surface water and sediment antibiotic resistance
5.2.2 Evaluation of resistance in surface water heterotrophs
Colonies isolated in the summer from Durand Beach exhibited 100% resistance to all four classes of antibi-
otics within this study. Resistance for isolates from Charlotte and Genesee was not determined as colonies
did not grow well on Bushnell Haas media. Payne Beach presented the highest resistance to cephalosporins
(53.3%), followed by aminoglycosides (30.0%), beta-lactams (22.5%), and fluoroquinolones (20.0%). Hem-
lock surface water heterotrophs exhibited resistance to cephalosporins (20.8%) and beta-lactams (6.3%), but
no resistance to fluoroquinolone (0.0%) or aminoglycoside (0.0%) antibiotics.
Colonies from Durand Beach cultured during the fall did not grow well on Bushnell Haas media; therefore
resistance was not determined for this site. Overall, the most resistance was observed to cephalosporin an-
tibiotics. Charlotte isolates presented the most resistance to cephalosporin (43.3%) and beta-lactam (37.5%)
antibiotics, followed by fluoroquinolones (6.7%) and aminoglycosides (5.0%) (Table 5.3). Similarly, Payne
Beach isolates displayed high frequencies of resistance to the cephalosporin (58.3%) and beta-lactam (34.4%)
CHAPTER 5. ANTIBIOTIC RESISTANCE 42
antibiotics, with lower resistance to fluoroquinolone (16.7%) and aminoglycoside (12.5%) antibiotics. As
anticipated, the drinking water source (Hemlock) did not exhibit resistance to any of the four classes of an-
tibiotics studied. Similarly, Genesee presented low resistance to the cephalosporin (9.5%), fluoroquinolone
(9.5%), beta-lactam (8.9%), and aminoglycoside (3.6%) antibiotics.
Antibiotic class Charlotte Durand Genesee Hemlock Payne
Surface water
Cephalosporin ND 100.0 ND 20.8 53.3
Beta-lactam ND 100.0 ND 6.3 22.5
Fluoroquinolone ND 100.0 ND 0.0 20.0
Aminoglycoside ND 100.0 ND 0.0 30.0
Sediment
Cephalosporin 72.9 56.7 38.9 21.4 50.0
Beta-lactam 73.4 50.0 8.3 21.4 39.2
Fluoroquinolone 72.9 56.7 38.9 21.4 50.0
Aminoglycoside 59.4 50.0 33.3 32.1 35.0
Values represent the percentage of colonies resistant to antibiotics within each
class, as specified in Table A.7. Equation (9) was used to obtain percentages.
ND, not determined as no isolates were cultured.
Table 5.2: Summer surface water and sediment antibiotic resistance
5.2.3 Evaluation of resistance in sediment heterotrophs
Heterotrophs cultured during the summer from sediment at Charlotte displayed high resistance in comparison
with the other sampling sites to the cephalosporin (72.9%), beta-lactam (73.4%), fluoroquinolone (72.9%),
and aminoglycoside (59.4%) antibiotics. Durand Beach displayed resistance to cephalosporin (56.7%), flu-
oroquinolone (56.7%), beta-lactam (50.0%), and aminoglycoside (50.0%) antibiotics. Of the Payne Beach
colonies isolated during the summer from sediment, there was 50% resistance to cephalosporin antibiotics, as
well as resistance to fluoroquinolone (50.0%), beta-lactam (39.2%), and aminoglycoside (35.0%) antibiotics.
Genesee displayed the highest resistance to cephalosporins (38.9%) and fluoroquinolones (38.9%), followed
by aminoglycoside (33.3%) and beta-lactam (8.3%) antibiotics. Hemlock displayed high resistance to amino-
glycoside (32.1%) antibiotics, followed by cephalosporin (21.4%), beta-lactam (21.4%), and fluoroquinolone
(21.4%) antibiotics.
Isolates cultured from fall sediment exhibited different resistance. Genesee demonstrated the highest re-
sistance to cephalosporin (91.7%) antibiotics, followed by beta-lactam (65.6%), aminoglycoside (37.5%),
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and fluoroquinolone (25.0%) antibiotics. Durand Beach displayed high resistance to the cephalosporin
(79.2%), beta-lactam (46.9%), and aminoglycoside (25.0%) antibiotics, but not resistant to fluoroquinolones.
Charlotte isolates displayed the highest resistance to aminoglycoside (95.0%) antibiotics, followed with the
cephalosporin (60.0), and beta-lactam (37.5%) antibiotics, but there was no resistance to fluoroquinolone
antibiotics. Durand Beach presented the highest resistance to cephalosporin (79.2%) antibiotics, followed
by resistance to beta-lactam (46.9%) and aminoglycoside (25.0%) antibiotics, with no resistance to fluoro-
quinolones. Payne Beach isolates were resistant to cephalosporin (54.2%), beta-lactam (34.4%), and amino-
glycoside (12.5%) antibiotics, but no resistance (0.0%) to fluoroquinolone antibiotics. Hemlock Lake isolates
displayed resistance to fluoroquinolones (22.2%), followed by cephalosporin (5.6%), and beta-lactam (4.2%)
antibiotics, but no resistance to aminoglycoside antibiotics.
Antibiotic class Charlotte Durand Genesee Hemlock Payne
Surface water
Cephalosporin 43.3 ND 9.5 0.0 58.3
Beta-lactam 37.5 ND 8.9 0.0 34.4
Fluoroquinolone 6.7 ND 9.5 0.0 16.7
Aminoglycoside 5.0 ND 3.6 0.0 12.5
Sediment
Cephalosporin 60.0 79.2 91.7 5.6 54.2
Beta-lactam 37.5 46.9 65.6 4.2 34.4
Fluoroquinolone 0.0 0.0 25.0 22.2 0.0
Aminoglycoside 95.0 25.0 37.5 0.0 12.5
Values represent the percentage of colonies resistant to antibiotics within each
class, as specified in Table A.7. Equation (9) was used to obtain percentages.
ND, not determined as no isolates were cultured.
Table 5.3: Fall surface water and sediment antibiotic resistance
Microbes isolated from fall dilutions enriched on cefepime from Charlotte were 55.6% resistant to cephalosporins,
25.0% resistant to beta-lactams, 0.0% resistant to fluoroquinolones, and 0.0% resistant to aminoglycosides.
Durand isolates enriched on cefepime were 16.7% resistant to cephalosporins, 12.5% resistant to beta-
lactams, 66.7% resistant to fluoroquinolones, and 25.0% resistant to aminoglycosides. Microbes cultured
from Genesee displayed 33.3% resistance to cephalosporins, 25.0% to beta-lactams, 33.3% to fluoroquinolones,
and 50.0% to aminoglycosides (Table 5.4).
Heterotrophs enriched on ampicillin from Charlotte were 41.7% resistant to cephalosporins, 31.3% resis-
tant to beta-lactams, 16.7% resistant to fluoroquinolones, and 25.0% resistant to aminoglycosides. Genesee
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isolates were 33.3% resistant to cephalosporins, 12.5% resistant to beta-lactams, 16.7% resistant to fluoro-
quinolones, and 25.0% resistant to aminoglycosides. Payne Beach isolates presented resistance of 50.0% to
cephalosporins, 12.5% to beta-lactams, 22.2% to fluoroquinolones, and 16.7% to aminoglycosides.
Microbes enriched on streptomycin from Charlotte were 100.0% resistant to cephalosporins, 100.0%
resistant to beta-lactams, 66.7% resistant to fluoroquinolones, and 25.0% resistant to aminoglycosides. Iso-
lates from Durand were documented with the resistance of 66.7% to cephalosporins, 62.5% to beta-lactams,
0.0% to fluoroquinolones, and 100.0% to aminoglycosides. Of Genesee isolates, 61.1% were resistant to
cephalosporins, 16.7% to beta-lactams, 33.3% to fluoroquinolones, and 16.7% aminoglycosides. Isolates
from Hemlock presented 50.0% resistance to cephalosporins, 43.8% to beta-lactams, 100.0% to fluoro-
quinolones, and 50.0% to aminoglycosides. Payne isolates attained resistance of 72.2% to cephalosporins,
70.8% to beta-lactams, 66.7% to fluoroquinolones, and 8.3% to aminoglycosides.
Heterotrophic microbes enriched on lomefloxacin from Charlotte were 88.9% resistant to cephalosporins,
62.5% to beta-lactams, 33.3% to fluoroquinolones, and 75.0% to aminoglycosides. Isolates from Hem-
lock presented resistance of 33.3% to cephalosporins, 12.5% to beta-lactams, 0.0% resistance to fluoro-
quinolones, and 0.0% resistance to aminoglycosides. Payne Beach heterotrophs presented resistance of
16.7% to cephalosporins, 25.0% to beta-lactams, 66.7% to fluoroquinolones, and 50.0% to aminoglycosides.
5.2.4 Calculated resistance in acclimated bacteria
Summer isolates enriched on the cephalosporin, cefepime, presented increased resistance to cephalosporin
antibiotics cultured from Charlotte (83.3%), Durand (83.3%), Genesee (100.0%), Hemlock (88.9%), and
Payne (83.3%). Beta-lactam resistance of cefepime enriched isolates was observed at 62.5% of antibiotics
from Charlotte, 87.5% of Durand, 62.5% of Genesee, 54.2% of Hemlock, and 75.0% of Payne. Fluoro-
quinolone resistance by these isolates was seen to 0.0% of antibiotics from Charlotte, 0.0% of Durand, 33.3%
of Genesee, 55.6% of Hemlock, and 33.3% of Payne. Heterotrophic microbes enriched on cefepime displayed
aminoglycoside resistance in 50.0% of Charlotte, 81.3% of Durand, 25.0% of Genesee, 58.3% of Hemlock,
and 25.0% of Payne (Table 5.5).
Isolates enriched on the beta-lactam, ampicillin, presented heightened antibiotic resistance to all classes
of antibiotics. Durand demonstrated resistance of 95.8% to cephalosporins, 75.0% to beta-lactam, 75.0%
to fluoroquinolone, and 68.8% to aminoglycoside antibiotics. Genesee exhibited a resistance of 91.7% to
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Antibiotic class Enriched on cefepime
Charlotte Durand Genesee Hemlock Payne
Cephalosporins 55.6 16.7 33.3 ND ND
Beta-lactam 25.0 12.5 25.0 ND ND
Fluoroquinolone 0.0 66.7 33.3 ND ND
Aminoglycoside 0.0 25.0 50.0 ND ND
Enriched on ampicillin
Charlotte Durand Genesee Hemlock Payne
Cephalosporins 41.7 ND 33.3 ND 50.0
Beta-lactam 31.3 ND 12.5 ND 12.5
Fluoroquinolone 16.7 ND 16.7 ND 22.2
Aminoglycoside 25.0 ND 25.0 ND 16.7
Enriched on streptomycin
Charlotte Durand Genesee Hemlock Payne
Cephalosporins 100.0 66.7 61.1 50.0 72.2
Beta-lactam 100.0 62.5 16.7 43.8 70.8
Fluoroquinolone 66.7 0.0 33.3 100.0 66.7
Aminoglycoside 25.0 100.0 16.7 50.0 8.3
Enriched on lomefloxacin
Charlotte Durand Genesee Hemlock Payne
Cephalosporins 88.9 ND ND 33.3 16.7
Beta-lactam 62.5 ND ND 12.5 25.0
Fluoroquinolone 33.3 ND ND 0.0 66.7
Aminoglycoside 75.0 ND ND 0.0 50.0
Values represent the percentage of colonies resistant to antibiotics within each
class, as specified in Table A.7. Equation (9) was used to obtain percentages.
ND, not determined as no isolates were cultured.
Table 5.4: Resistance of enriched fall isolates
cephalosporins, 81.3% to beta-lactams, 33.3% to fluoroquinolones, and 87.5% to aminoglycosides. Colony
resistance from Charlotte, Hemlock, and Payne enriched on ampicillin were not determined.
Colonies enriched on the aminoglycoside, streptomycin, from Charlotte were 100.0% resistant to cephalosporins,
37.5% resistant to beta-lactams, 33.3% resistant to fluoroquinolones, and 75.0% resistant to aminoglyco-
sides. Payne isolates enriched on streptomycin were 83.3% resistant to cephalosporins, 58.3% resistant to
beta-lactams, 88.9% resistant to fluoroquinolones, and 33.3% resistant to aminoglycosides.
Heterotrophic microbes enriched on lomefloxacin, a fluoroquinolone antibiotic, from Charlotte were
100.0% resistant to cephalosporins, 87.5% resistant to beta-lactams, 100.0% resistant to fluoroquinolones,
and 100.0% resistant to aminoglycosides. Microbes from Durand were 83.3% resistant to cephalosporins,
37.5% resistant to beta-lactams, 66.7% resistant to fluoroquinolones, and 0.0% resistant to aminoglycosides.
CHAPTER 5. ANTIBIOTIC RESISTANCE 46
Colonies from Payne were 83.3% resistant to cephalosporins, 75.0% resistant to beta-lactams, 0.0% resistant
to fluoroquinolones, and 25.0% resistant to aminoglycosides.
Antibiotic class Enriched on cefepime
Charlotte Durand Genesee Hemlock Payne
Cephalosporins 83.3 83.3 100.0 88.9 83.3
Beta-lactam 62.5 87.5 62.5 54.2 75.0
Fluoroquinolone 0.0 0.0 33.3 55.6 33.3
Aminoglycoside 50.0 81.3 25.0 58.3 25.0
Enriched on ampicillin
Charlotte Durand Genesee Hemlock Payne
Cephalosporins ND 95.8 91.7 ND ND
Beta-lactam ND 75.0 81.3 ND ND
Fluoroquinolone ND 75.0 33.3 ND ND
Aminoglycoside ND 68.8 87.5 ND ND
Enriched on streptomycin
Charlotte Durand Genesee Hemlock Payne
Cephalosporins 100.0 ND ND ND 83.3
Beta-lactam 37.5 ND ND ND 58.3
Fluoroquinolone 33.3 ND ND ND 88.9
Aminoglycoside 75.0 ND ND ND 33.3
Enriched on lomefloxacin
Charlotte Durand Genesee Hemlock Payne
Cephalosporins 100.0 83.3 ND ND 83.3
Beta-lactam 87.5 37.5 ND ND 75.0
Fluoroquinolone 100.0 66.7 ND ND 0.0
Aminoglycoside 100.0 0.0 ND ND 25.0
Values represent percentage of colonies resistant to antibiotics within each
class, as specified in Table A.7. Equation (9) was used to obtain percentages.
ND, not determined as no isolates were cultured.
Table 5.5: Resistance of enriched summer isolates
5.2.5 Susceptibility of robust sediment isolates
Antibiotic susceptibility of robust isolates is shown in Table 5.6. Unknown 1, cultured from Durand Eastman
Beach in the summer and enriched on ampicillin, was resistant to a total of 19 out of 24 (79.2%) antibiotics
tested within this study. Unknown 2, also from Durand Beach cultured in the summer, was enriched on
cefepime and displayed resistance to 16 (66.7%) different antibiotics. The Charlotte heterotroph (unknown
3) cultured during the summer and enriched on cefepime was resistant to 12 (50.0%) of the antibiotics tested.
Unknown 4, cultured from Durand Beach during the summer and enriched on cefepime was resistant to 15
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(62.5%) antibiotics.
Microbes (unknowns 5-7) were used for degradation studies and cultured during the fall. Unknown
5, from Durand and enriched on streptomycin, was resistant to 14 (58.3%) antibiotics under investigation.
Payne Beach isolate enriched on ampicillin demonstrated resistance to 7 (29.2%) antibiotics. Similarly, the
Genesee isolate enriched on cefepime was resistant to 7 (29.2%) of a total of 24 different antibiotics assessed
for microbial susceptibility using the Kirby-Bauer disc diffusion method.
Antibiotic Unknown NR
1 2 3 4 5 6 7
Amikacin R R S S R I R 4
Ampicillin R R R R R S S 5
Carbenicillin R R R R R S R 6
Cefazolin R R R R R R S 6
Cefepime R S R S S S S 2
Cefixime R R R R R R R 7
Cefoxitin R I R R R S R 5
Ceftriaxone S R S R I R S 3
Cephalothin R R R R R S S 5
Chloramphenicol R R S R R R S 5
Ciprofloxacin R S S S S S R 2
Co-amoxiclav S R S R S S S 2
Co-trimoxazole R I S S S S S 1
Doxycycline R S S S S S S 1
Gentamicin R R S S R S S 3
Imipenem S S S S S S S 0
Levofloxacin S S S S S S S 0
Lomefloxacin S I S S S S S 0
Mezlocillin R R R R R S S 5
Oxacillin R R R R R R R 7
Piperacillin R R R R I S S 4
Streptomycin R R R R R R R 7
Ticarcillin R R S R R S S 4
Tobramycin R R R R R R S 6
NR 19 16 12 15 14 7 7 90
Antibiotic resistance of robust unknown isolates. Refer to Table A.14
for unknowns. The following unknowns were originally enriched on
the corresponding antibiotics: 1 and 6 (ampicillin), 2-4 and 7 (ce-
fepime), 5 (streptomycin). NR, total occurrence of resistance; co-
amoxiclav, amoxicillin/ clavulanic acid; co-trimoxazole, trimetho-
prim/ sulfamethoxazole.
Table 5.6: Antimicrobial susceptibility of robust isolates
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It is notable to mention that all of the unknowns cultured were resistant to cefixime, oxacillin, and strep-
tomycin. On the other hand, resistance to imipenem, levofloxacin, and lomefloxacin was not observed in
these high capacity isolates. Furthermore, isolates cultured from Durand (1, 2, 4, 5) were resistant to ampi-
cillin, carbenicillin, cefazolin, cefixime, cephalothin, chloramphenicol, mezlocillin, oxacillin, streptomycin,
ticarcillin, and tobramycin.
Table 5.7 presents the resistance of colonies to antibiotics grouped by class by high capacity unknown
isolates enriched on various antibiotics. Unknowns enriched on ampicillin (1, 6) were resistant to 75.0%
of aminoglycoside, 43.8% of beta-lactam, 66.7% of cephalosporin, and 16.7% of fluoroquinolone antibi-
otics. Microorganisms enriched on cefepime (2-4, 7) were resistant to 62.5% of aminoglycoside, 65.6%
of beta-lactam, 66.7% of cephalosporin, and 8.3% of fluoroquinolone antibiotics. Unknown 5, enriched on
streptomycin, was resistant to 100.0% of aminoglycoside, 62.5% of beta-lactam, 66.7% of cephalosporin,
and 0.0% of fluoroquinolone antibiotics.
Nantibiotics Antibiotic class Enriched substrate
Ampicillin Cefepime Streptomycin
4 Aminoglycoside 6 (75.0) 10 (62.5) 4 (100.0)
8 Beta-lactam 7 (43.8) 21 (65.6) 5 (62.5)
6 Cephalosporin 8 (66.7) 16 (66.7) 4 (66.7)
3 Fluoroquinolone 1 (16.7) 1 (8.3) 0 (0.0)
Antibiotic resistance of robust unknown isolates grouped by enriched sub-
strate. Nantibiotics, number of antibiotics tested in each antibiotic class.
Table 5.7: Resistance of robust isolates, grouped by enriched substrate, to an-
tibiotic classes
5.2.6 Classification of robust heterotrophs
Robust isolates were further assessed by observing colony morphology, Gram stain, and appearance on cul-
ture media (Tables A.8 and A.9). Unknown 1, cultured from Durand sediment and formerly enriched on
ampicillin, appeared Gram-negative with short bacilli under immersion oil, and on culture media demon-
strated mustard yellow pigmentation with punctiform, flat, and entire morphology. Unknown 2, cultured
from Durand sediment and formerly enriched on cefepime, had Gram-negative cocci chains greater than five
and pale yellow pigmentation on culture media with circular, convex, and entire morphology. Unknown 3,
cultured from Charlotte sediment and enriched on cefepime, was observed to be Gram-negative with chain
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forming, short bacilli greater than five, and on media appeared translucent white with circular, raised, and
entire morphology. Unknown 3, cultured from Durand sediment and enriched on cefepime, appeared to be
Gram-negative with short bacilli and on media appeared beige with circular, raised, and entire morphology
(Figure B.8).
Unknown 5, cultured from Durand fall sediment, and initially enriched on streptomycin, was phenotypi-
cally observed to be circular, convex, and entire with pigmentation characterized as off-white. Furthermore,
unknown 5, when observed under immersion oil using light microscopy, appeared Gram-negative with cocci
chains less than five. Unknown 6, cultured from Payne Beach sediment and enriched on ampicillin, was de-
termined to be Gram-negative with diplococci and on culture media appeared marigold with circular, raised,
and entire morphology. Unknown 7, cultured from Genesee sediment and initially enriched on cefepime, was
Gram-variable with short and long bacilli that appeared to have terminal endospores, and was vivid white
with circular, flat, and undulate morphology on culture media (Figure B.9).
5.3 Discussion
5.3.1 Antibiotic resistance heightened by wastewater pollution
The resistance of microorganisms in the environment is of great concern as microbes are gaining antibiotic
resistance faster than new drugs can be developed [21]. In this study, heterotrophs from five sampling sites in
Western New York were resistant to varying combinations of 24 different antibiotics. We found that sites with
direct wastewater effluent pollution presented a clear association with antibiotic resistance. These findings are
justifiable as prior studies have observed increased antibiotic resistance of sediment coliforms downstream of
an effluent pipe in comparison with upstream [75], [76].
As predicted, the antibiotic resistance of sediment bacteria was increased in Charlotte, Durand, and Payne
Beaches and the Genesee River, which receive wastewater effluents. In contrast, antibiotic resistance by
microbes isolated from Hemlock Lake was significantly lower. These results are consistent with the notion
of a correlation existing between wastewater effluents and antibiotic resistance.
In particular, all of the summer Durand surface water isolates were resistant to every antibiotic under
investigation. These results suggest that Durand Beach is heavily polluted with high antibiotic loads from
Van Lare WWTP and surrounding industrial and municipal facilities, such as Walter W Bradley WPCF, on
the southeastern coast of Lake Ontario within the HUC region 04140101.
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Charlotte Beach may have high effluent concentrations of heavy metals from Kodak and RG&E Beebee
Station, which may induce selection of ARGs. Additionally, Charlotte Beach is the receiving water body of
the Genesee River that is subject to hospital effluent from Rochester Regional Health and Highland Hospital,
which may have increased beta-lactam, cephalosporin, fluoroquinolone, and aminoglycoside antibiotic levels
as suggested through observations of antibiotic resistance by heterotrophs in this study.
Surprisingly, Hemlock Lake sediment isolates presented moderate resistance to cephalosporin, beta-
lactam, fluoroquinolone, and aminoglycoside antibiotics, suggesting that a small amount of Consensus Lake
County Sewer District effluent may be seeping into Hemlock Lake despite it being located approximately 10
miles away. Other discharge may also be influencing the properties of heterotrophs in Hemlock Lake. It is
worthy of mentioning that Hemlock is stocked with fish [77], which may unintentionally cause microbes to
gain resistance. Heavy metal discharge has been observed to carry along antibiotic resistance genes [69]. Al-
ternatively, this observed resistance may have been due to human error, like, contamination of grab samples
or culture.
Within this study, cephalosporins appeared to be the antibiotic class with the most observed antibiotic
resistance across all sampling sites, followed by beta-lactams, aminoglycosides, and fluoroquinolones. These
results are likely due to the interactions between the following factors: bioaccumulation of toxicants in water
and sediments over time, the number of antibiotics prescribed and discharged, and persistence of chemical
compounds in the environment.
Antibiotic resistance observed in surface waters followed the same pattern in terms of the influence of
effluent. Prior studies have noted that antibiotic resistance in surface waters was observed to be lower than
that of sediments [40], which is likely due to increased settling out of pollutants into the sediment. In this
study, antibiotic resistance of surface water heterotrophs from Durand Beach was significantly increased in
comparison to sediments. These results suggest that effluent containing high antibiotic concentrations may
have recently been discharged to the water or that microbes in the sediment are reversing the process of
antibiotic resistance through a self-cleansing process.
Prior studies on the exposure of microorganisms to high levels of antibiotics have proven that this allows
for the selection of ARGs for the survival of organisms [78]. Therefore, high amounts of antibiotic resistance
may suggest specific indications in highly polluted environments. Results are indicative of observed antibi-
otic resistance as a direct impact of wastewater effluents through the selective pressure of highly polluted
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environments.
5.3.2 Resistance induced by short-term and high-concentration exposure
The resistance of microbes to various classes of antibiotics following the extended exposure to a single an-
tibiotic is of great importance as multi-resistant human pathogens are resulting in high morbidity and calling
for a worldwide public health crisis [21], [79], [80]. We found that across five sampling sites, regardless of
wastewater effluent presence in the environment, the exposure of isolates to cefepime, ampicillin, strepto-
mycin, and lomefloxacin separately induced the occurrence of antibiotic resistance of sediment microbes in
vitro.
The enrichment of sediment isolates on cefepime resulted in high observed antibiotic resistance to cephalo-
sporins, beta-lactams, and aminoglycosides in isolates from all five sampling sites. Cefepime enrichment also
increased the prevalence of fluoroquinolone resistance in heterotrophs from Genesee, Hemlock, and Payne.
It was surprising that Hemlock Lake presented high amounts of antibiotic resistance because un-amended
sediment isolates were not as resistant to antibiotics, which may be due to the lack of effluent discharged into
the lake. These results suggest that duration as short as a 21-day exposure to elevated antibiotic levels may
be enough to induce antibiotic resistance to a wide array of compounds in environments regardless of prior
environmental pollution.
The enrichment of sediments on ampicillin, a beta-lactam antibiotic, appeared to increase antibiotic re-
sistance to all 24 antibiotics by heterotroph isolates from Durand and Genesee. Interestingly, the enrichment
of ampicillin seemed to induce beta-lactam antibiotic resistance.
Similarly, the enrichment on an aminoglycoside antibiotic, streptomycin, increased microbial resistance
to aminoglycosides of isolates cultured from Charlotte Beach when compared with isolates that were enriched
on another antibiotic. In comparison, Payne Beach isolates resistance to aminoglycosides increased slightly,
but was not as high as those observations from Charlotte. Surprisingly, the enrichment on streptomycin
appeared to influence the likelihood of microbes to survive in the presence of other antibiotics.
The enrichment of cultures with lomefloxacin, a fluoroquinolone, appeared to influence and increase
fluoroquinolone resistance when compared to isolates enriched with other antibiotics as with Charlotte and
Durand isolates. It is important to mention that this was not the case with Hemlock isolates enriched on
lomefloxacin.
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These results suggest that short duration and high exposure of heterotrophs to antibiotics, as observed in
highly polluted environments, may increase the likelihood of microbial survival and resistance to alternative
antibiotics in sediments.
5.3.3 Robust isolate resistance assessment
The resistance of unknown microbial isolates used for the removal of various pharmaceuticals is of particular
significance as there may be a relationship between antibiotic resistance and biodegradation. Durand Beach
isolate, unknown 1 enriched on ampicillin, was resistant to 79% of antibiotics examined within this study. It
is important to mention that unknown 1 was also the isolate that degraded the majority of available carbon
from ampicillin during degradation studies. These results suggest that there may be a common denominator
between antibiotic resistance and degradation in environmental heterotrophs of highly polluted environments
in Western New York that must be studied in greater depth.
Alternatively, recent studies have hypothesized that the formation of biofilms in conjunction with nutrient
limitation assists in the survival of microbes with antibiotics [81]. These findings are relevant in this context
as, despite their degradation capabilities, unknowns 1, 2, 3, 4, and 5 were 85.7%, 66.7%, 83.3%, 83.3%, and
100.0% resistant to antibiotics in the same class (Table A.6) by which they were selected for, respectively,
suggesting that their survival may be due to biofilm formation and nutrient-limitation ex situ. Tables A.12 and
A.13 indicate visual detection of a mass of cells, most possibly a biofilm, in the culture following incubation.
Qualitative observations of growth signify that unknowns 2, 4, and 7 presented visual detection of biofilm
formation, therefore, the resistance observed should be carefully considered.
5.4 Conclusion
Point source pollution from industrial and municipal wastewater induces selective pressure on environmental
microorganisms, thereby favoring resistance traits for survival. This notion above is supported in this study as
heightened antibiotic resistance to cephalosporin, beta-lactam, fluoroquinolone, and aminoglycoside antibi-
otics were observed at sampling sites located in water bodies that receive wastewater directly in comparison
with water used as a drinking source. Furthermore, antibiotic resistance was induced in drinking-water source
sediment cultures exposed to extremely high concentrations of antibiotic which dramatically heightened the
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survival of microbes with antibiotic resistance in the culture. We postulate that wastewater pollution pro-
motes resistance within the gene pool, which may be suppressed under certain conditions. Moreover, the
degradation capabilities of heterotrophs to specific substrates in contaminated sediments is observed in par-
allel with antibiotic resistance of these substrates, suggesting proximity and selective advantage of genes for
multiresistance and biodegradation. We hypothesize that wastewater pollution increases antibiotic resistance
of heterotrophs in freshwater and soil environments.
Chapter 6
Recommendations for future research
It is essential to understand metabolic functions that improve biodegradation. To implement these technolo-
gies, a basic understanding of the factors that control biodegradation efficiency is necessary. The metabolic
factors of biodegradation can be applied to several applications of soil remediation [82]. In this study, we
identify key factors impacting the metabolism of antibiotics in soil heterotrophs. An understanding of the
genes involved in biodegradation can be useful for the improvement of phytoremediation in polluted environ-
ments [82].
For bioremediation of antibiotics in contaminated soil environments to be improved, future research must
focus on:
• The use of transcriptomics to induce the expression and alteration of biodegradation genes under con-
taminated conditions [82].
• Proteomics can be used to identify changes in protein expression in response to stress [82].
• Metabolomics technology can be used to understand biodegradation under contaminated conditions
[82].
• Metabolic engineering of microbes [83].
Future research should identify critical genes involved in biodegradation to improve removal of toxic
substances in contaminated soil environments. The regulation of specific genes involved in this process can
initiate bioremediation in the absence of environmental stressors of contaminated environments by targeting
gene expression [82].
The use of riboswitch technology is an intriguing idea that can be applied using the knowledge within
this study. Riboswitch technology has critical applications for the bioremediation of contaminated soils. With
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an understanding of the physiological regulations of gene expression, riboswitches can be genetically engi-
neered to turn genes on or off for the translation of key enzymatic proteins involved in biodegradation [82].
For instance, we found that under high concentrations of a primary substrate, the metabolism of alternative
substrates is enhanced.
Successful manipulation of metabolic pathways has been performed using clustered regularly interspaced
short palindromic repeats-CRISPR associated protein 9 (CRISPR-Cas9) tools. Moreover, studies have iden-
tified key enzymes involved in contaminant degradation. Gene editing tools can be used to overexpress these
genes to clean contaminants from soil [82]. These genes can be identified by the use of the conditions of this
study, then apply that knowledge to improve the bioremediation of antibiotics in soil.
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Appendix A
Supplemental tables
Tests of Between-Subjects Effects
Dependent Variable: Water Cell Counts
Source Type III SS df Mean Square F Sig.
Corrected Model 1.53x1016a 9 1.698x1015 1338.392 0.000
Intercept 4.351x1015 1 4.351x1015 3428.886 0.000
Season 3.833x1015 1 3.833x1015 3020.457 0.000
Site 5.555x1015 4 1.389x1015 1094.351 0.000
Season * Site 5.898x1015 4 1.474x1015 1161.916 0.000
Error 2.538x1013 20 1.269x1012
Total 1.966x1016 30
Corrected Total 1.531x1016 29
a. R Squared = 0.998 (Adjusted R Squared = 0.998)
SS, sum of squares.
Table A.1: Effect of sampling location and season on concentrations of cultur-
able microorganisms in water
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Tests of Between-Subjects Effects
Dependent Variable: Sediment Cell Counts
Source Type III SS df Mean Square F Sig.
Corrected Model 1.54x1016a 9 1.716x1015 46.557 0.000
Intercept 7.709x1015 1 7.709x1015 209.155 0.000
Season 7.283x1015 4 1.821x1015 49.401 0.000
Site 1.580x1015 1 1.580x1015 42.862 0.000
Season * Site 6.581x1015 4 1.645x1015 44.638 0.000
Error 7.371x1014 20 3.686x1013
Total 2.389x1016 30
Corrected Total 1.618x1016 29
a. R Squared = 0.954 (Adjusted R Squared = 0.934)
SS, sum of squares.
Table A.2: Effect of sampling location and season on concentrations of culturable
microorganisms in sediment
Facility name T (lb) LOL (lb) HUC 8
Avon STP 3.01x105 0 04130003
Bradley WPCF 2.16x106 0 04140101
Consensus Sewer 1.53x105 0 04130003
Hemlock WFP 5.36x104 6.19x103 04130003
Honeoye WWTP 6.35x104 6.32x102 04130003
Kodak 6.72x107 2.23x10-3 04130003
Leroy WWTP 5.24x104 0 04130003
NWQ WWTP 3.88x106 4.26x103 04130001
Van Lare WWTP 3.63x107 1.61x106 04140101
Xerox 1.03x107 2.36x103 04140101
Refer to Table A.4 for sampling sites within each water-
shed boundary. T, total pounds of pollutants discharged
from the facility between 2015 and 2017; LOL, total load
over limit for numeric permits; Avon STP, Avon Sewage
Treatment Plant; Bradley WPCF, Walter W. Bradley Wa-
ter Pollution Control Facility; Consensus Sewer, Consen-
sus Lake County Sewer District; Hemlock WFP, Hemlock
Water Filtration Plant; Honeoye WWTP, Honeoye Falls
WWTP; Kodak, Eastman Kodak Company; NWQ WWTP,
Northwest Quadrant Pure Waters District No. 1; Xerox,
Xerox Joseph C Wilson Center For Technology.
Table A.3: Facilities with effluent limit exceedances
(2015-2017)
APPENDIX A. SUPPLEMENTAL TABLES 69
Site HUC 8
Charlotte 04130003
Durand 04140101
Genesee 04130003
Hemlock 04130003
Payne 04130001
Table A.4: HUC 8 region
of sampling sites
Antibiotic m V ρ (g/l) ρ (µg/ml)
Amoxicillin 125 20 6.25 6250
Ampicillin* 150 20 7.50 7500
Cefepime* 150 20 7.50 7500
Chloramphenicol 25 20 1.30 1300
Erythromycin 250 20 12.5 12500
Levofloxacin 500 20 25.0 25000
Lomefloxacin* 500 20 25.0 25000
Streptomycin* 200 20 10.0 10000
Tetracycline 10 20 0.50 500
Trimethoprim 50 20 2.50 2500
ρ, mass concentration of substrate; m, mass of antibiotic
substrate in milligrams; V, volume of Bushnell Haas in
milliliters; *, antibiotics used in original enrichments.
Table A.5: Preparation of antibiotic stock solutions
Unknown Enriched substrate Antibiotic class % resistance
1 Ampicillin Beta-lactam 85.7
2 Cefepime Cephalosporin 66.7
3 Cefepime Cephalosporin 83.3
4 Cefepime Cephalosporin 83.3
5 Streptomycin Aminoglycoside 100.0
6 Ampicillin Beta-lactam 14.3
7 Cefepime Cephalosporin 33.3
% resistance, percent resistance too all antibiotics considered for each
class. Refer to Table A.7 for groupings of antibiotics.
Table A.6: Percent resistance of unknown isolates to selected antibi-
otic class
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Aminoglycoside Beta-lactam Cephalosporin Fluoroquinolone
Amikacin Co-amoxiclav Cefazolin Ciprofloxacin
Gentamicin Ampicillin Cefepime Levofloxacin
Streptomycin Carbenicillin Cefixime Lomefoxacin
Tobramycin Imipenem Cefoxitin
Mezlocillin Cephalothin
Oxacillin Ceftriaxone
Piperacillin
Ticarcillin
Co-amoxiclav, amoxicillin/ clavulanic acid.
Table A.7: Antibiotics split into classes
Unknown Location Gram reaction Morphology
1 Durand Negative Short bacilli
2 Durand Negative Cocci chains >5
3 Charlotte Negative Short bacilli >5, chain forming
4 Durand Negative Short bacilli
5 Durand Negative Cocci chain <5
6 Payne Negative Diplococci
7 Genesee Variable Short and long bacilli
Table A.8: Unknown isolate characteristics
Unknown Location Form, elevation, margin Pigmentation
1 Durand Punctiform, flat, entire Mustard yellow
2 Durand Circular, convex, entire Pale yellow
3 Charlotte Circular, raised, entire Translucent white
4 Durand Circular, raised, entire Beige
5 Durand Circular, convex, entire Off-white
6 Payne Circular, raised, entire Marigold
7 Genesee Circular, flat, undulate Vivid white
Table A.9: Unknown isolate appearance
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Tukey HSDa,b
Subset
Site N 1 2
Charlotte 6 5.0x105
Durand 6 7.8x105
Payne 6 1.5x106
Genesee 6 2.8x107
Hemlock 6 2.9x107
Sig. 0.521 0.613
Means for groups in homogeneous subsets
are displayed. Based on observed means.
a. Uses Harmonic Mean Sample Size =
6.000.
b. Alpha = 0.05.
Table A.10: Post-Hoc Tukey test for water
cell counts
Tukey HSDa,b
Subset
Site N 1 2 3
Charlotte 6 1.37x106
Durand 6 4.37x106
Payne 6 5.95x106
Genesee 6 2.72x107
Hemlock 6 4.13x107
Sig. 0.690 1.000 1.000
Means for groups in homogeneous subsets are displayed.
Based on observed means.
a. Uses Harmonic Mean Sample Size = 6.000.
b. Alpha = 0.05.
Table A.11: Post-Hoc Tukey test for sediment cell counts
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Site Ampicillin Cefepime Lomefloxacin Streptomycin
Charlotte (+) (+) (+) (+)
Durand (+/-) (+/-) (+/-) (+/-)
Genesee (++) (++) (++) (++)
Hemlock (+) (+) (+) (+)
Payne (+) (+) (+) (+)
(a) Enrichment 1
Site Ampicillin Cefepime Lomefloxacin Streptomycin
Charlotte (+) (+/-) (+) (+)
Durand (+) (+) (+) (+)
Genesee (++) (++) (++) (++)
Hemlock (+) (+/-) (+/-) (+)
Payne (+) (+/-) (+/-) (+)
(b) Enrichment 2
Site Ampicillin Cefepime Lomefloxacin Streptomycin
Charlotte (++)* (+)† (++) (+)*
Durand (+)† (++)*† (++)* (+)*
Genesee (++) (++) (+) (+)
Hemlock (++) (++)* (++)* (+)
Payne (+) (++)* (+) (+)*
(c) Enrichment 3
(+), regular growth/ turbidity; (++), ample growth/ turbidity; (-), no growth/ turbidity; (+/-), some growth/
turbidity; *, enrichment 3 cultures with floaters/ mass of clumpy growth; †, flask used to culture unknown
high capacity isolates.
Table A.12: Qualitative growth of heterotrophs from sediments during summer enrichments
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Site Ampicillin Cefepime Lomefloxacin Streptomycin
Charlotte (+/-) (+) (+/-) (+)
Durand (+) (+) (+) (+)
Genesee (++) (++) (++) (++)
Hemlock (++) (++) (++) (++)
Payne (+) (+) (+) (+)
(a) Enrichment 1
Site Ampicillin Cefepime Lomefloxacin Streptomycin
Charlotte (+/-) (+) (+) (+)
Durand (+/-) (+) (+) (+)
Genesee (++) (++) (++) (+/-)
Hemlock (++) (++) (++) (++)
Payne (+) (+) (+) (+/-)
(b) Enrichment 2
Site Ampicillin Cefepime Lomefloxacin Streptomycin
Charlotte (+) (+)* (+)* (+/-)*
Durand (+/-) (+)* (+)* (++)†
Genesee (+) (+)*† (+) (+)*
Hemlock (++) (++) (++) (++)*
Payne (+)† (+)* (++)* (+)
(c) Enrichment 3
(+), regular growth/ turbidity; (++), a lot of growth/ turbidity; (-), no growth/ turbidity; (+/-), some growth/
turbidity; *, enrichment 3 cultures with floaters/ mass of clumpy growth; †, flask used to culture unknown
high capacity isolates.
Table A.13: Qualitative growth of heterotrophs from sediments during fall enrichments
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Unknown Sampling site Enriched on Season
1 Durand Ampicillin Summer
2 Durand Cefepime Summer
3 Charlotte Cefepime Summer
4 Durand Cefepime Summer
5 Durand Streptomycin Fall
6 Payne Ampicillin Fall
7 Genesee Cefepime Fall
8 Durand Ampicillin Summer
9 Durand Ampicillin Summer
10 Genesee Ampicillin Summer
11 Durand Cefepime Summer
12 Durand Cefepime Summer
13 Genesee Cefepime Summer
14 Hemlock Cefepime Summer
15 Payne Cefepime Summer
16 Charlotte Lomefloxacin Summer
17 Durand Lomefloxacin Summer
18 Payne Lomefloxacin Summer
19 Charlotte Streptomycin Summer
20 Payne Streptomycin Summer
21 Payne Streptomycin Summer
22 Payne Streptomycin Summer
23 Charlotte Ampicillin Fall
24 Genesee Ampicillin Fall
25 Charlotte Cefepime Fall
26 Charlotte Cefepime Fall
27 Charlotte Lomefloxacin Fall
28 Charlotte Lomefloxacin Fall
29 Genesee Lomefloxacin Fall
30 Hemlock Lomefloxacin Fall
31 Genesee Streptomycin Fall
32 Genesee Streptomycin Fall
33 Hemlock Streptomycin Fall
34 Hemlock Streptomycin Fall
35 Payne Streptomycin Fall
Unknowns 1 to 7 were chosen for further analyses based
upon high growth rate and short doubling times during the
growth analysis phase.
Table A.14: Identification of unknowns used within this
study
APPENDIX A. SUPPLEMENTAL TABLES 75
Zone standards (mm)
Antimicrobial Agent Code Disc Potency R I S
Amikacin AN-30 30µg ≤14 15-16 ≥17
Co-amoxiclav AmC-30 20/10µg ≤13 15-16 ≥17
Ampicillin AM-10 10µg ≤13 14-16 ≥17
Carbenicillin CB-100 100µg ≤19 20-22 ≥23
Cefazolin CZ-30 30µg ≤14 15-17 ≥18
Cefepime FEP-30 30µg ≤14 15-17 ≥18
Cefixime CFM-5 5µg ≤15 16-18 ≥19
Cefoxitin FOX-30 30µg ≤14 15-17 ≥18
Cephalothin CF-30 30µg ≤14 15-17 ≥18
Chloramphenicol C-30 30µg ≤12 13-17 ≥18
Ceftriaxone CRO-30 30µg ≤13 14-20 ≥21
Ciprofloxacin CIP-5 5µg ≤15 16-20 ≥21
Doxycycline D-30 30µg ≤12 13-15 ≥16
Gentamicin GM-120 120µg ≤12 13-14 ≥15
Imipenem IPM-10 10µg ≤13 14-15 ≥16
Levofloxacin LVX-5 5µg ≤13 14-16 ≥17
Lomefloxacin LOM-10 10µg ≤18 19-21 ≥22
Mezlocillin MZ-75 75µg ≤17 18-20 ≥21
Oxacillin OX-1 1µg ≤10 11-12 ≥13
Piperacillin PIP-100 100µg ≤17 18-20 ≥21
Streptomycin S-300 300µg ≤11 12-14 ≥15
Ticarcillin TIC-75 75µg ≤14 15-19 ≥20
Tobramycin NN-10 10µg ≤12 13-14 ≥15
Co-trimoxazole SXT 1.25µg ≤10 11-15 ≥16
23.75µg
Zone standards (mm); zone diameter standards in millimeters; co-amoxiclav,
amoxicillin/ clavulanic acid; co-trimoxazole, trimethoprim/ sulfamethoxa-
zole. The table was adapted using the reference sheet from Becton, Dickin-
son and Company, 2011 BD [64].
Table A.15: Kirby-Bauer zone standards for determining bacterial suscepti-
bility
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Figure B.1: Flow chart of methodology
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Figure 3. Antibiotics used in antibiotic co-selection enrichment and biodegradation 
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Structures adapted using iChemLabs (2018) software (Bhattacharjee, 2016; 
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antibiotic biodegradation in this study. 
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Figure 3. Antibiotics used in antibiotic co-selection enrichment and biodegradation 
 
 
 
 
Amoxicillin a 
 
 
 
 
Chloramphenicol b 
 
 
 
Eryt ro y n c 
 
 
 
Levofloxacin d 
 
 
 
Doxycycline e 
 
Trimethoprim f 
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Structures adapted using iChemLabs (2018) software (Bhattacharjee, 2016; 
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Figure 3. Antibiotics used in antibiotic co-selection enrichment and biodegradation 
 
 
 
 
Amoxicillin a 
 
 
 
 
Chloramphenicol b 
 
 
 
rythromyci  c 
 
 
 
Levofloxacin d 
 
 
 
Doxycycline e 
 
Trimethoprim f 
Note. — Antibiotic class: a. ß-lactam; b. chloramphenicol; c. macrolide; d. 
fluoroquinolone; e. tetracycli e; f. trimethoprim. 
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antibiotic biodegradation in this study. 
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Figure 3. Antibiotics used in antibiotic co-selection enrichment and biodegradation 
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Figure B.3: Chemical structures of ant biotics used for al-
ternate substrate metabolism
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Figure B.4: Sampling locations in Western New York
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Figure was generated using iChemLabs (2018) software [87].
Figure B.5: Serial dilutions technique for water and sediment
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Figure was generated using iChemLabs (2018) software [87].
Figure B.6: Enrichment technique
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Figure was generated using iChemLabs (2018) software [87].
Figure B.7: Enrichment technique
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A, unknown 1 from Durand Beach and enriched on ampicillin; B, unknown 2 from Durand Beach and
enriched on cefepime; C, unknown 3 from Charlotte Beach and enriched on cefepime; D, unknown 4 from
Durand Beach and enriched on cefepime.
Figure B.8: Gram stain of unknowns 1-4
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E, unknown 5 from Durand Beach and enriched on streptomycin; F, unknown 6 from Payne Beach and
enriched on ampicillin; G, unknown 7 from the Genesee River and enriched on cefepime.
Figure B.9: Gram stain of unknowns 5-7
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Figure B.10: Degradation of ampicillin by unknown 1 from Durand Beach
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Figure B.11: Degradation of cefepime by unknown 2 from Durand Beach
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Figure B.12: Degradation of cefepime by unknown 3 from Charlotte Beach
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Figure B.13: Degradation of cefepime by unknown 4 from Durand Beach
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Figure B.14: Degradation of streptomycin by unknown 5 from Durand Beach
APPENDIX B. SUPPLEMENTAL FIGURES 88
Time (Days)
1086420
M
ill
ig
ra
m
s o
f C
ar
bo
n 
D
io
xi
de
 E
vo
lv
ed
1.50
1.00
.50
.00
12.38
8.25
4.12
Available Carbon (mg)
Page 1
Figure B.15: Degradation of ampicillin by unknown 6 from Payne Beach
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Figure B.16: Degradation of cefepime by unknown 7 from the Genesee River
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Figure B.17: Degradation of alternate substrates by unknown 1
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Figure B.18: Degradation of alternate substrates by unknown 2
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Figure B.19: Degradation of alternate substrates by unknown 3
0.0 2.0 4.0 7.0 10.0
0
0.2
0.4
0.6
0.8
1
1.2
Time (Days)
M
ill
ig
ra
m
s
of
C
O
2
E
vo
lv
ed
Degradation of alternate substrates by unknown 4
Alternate Substrate
Erythromycin (22.7)
Levofloxacin (44.87)
Tetracycline (0.30)
The total milligrams of carbon available for a particular substrate are indicated in the legend.
Figure B.20: Degradation of alternate substrates by unknown 4
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Figure B.21: Degradation of alternate substrates by unknown 5
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Figure B.22: Degradation of alternate substrates by unknown 6
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Figure B.23: Degradation of alternate substrates by unknown 7
